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The immune response to mycobacteria is characterized by granuloma formation, which
features multinucleated giant cells as a unique macrophage type. We previously found that
multinucleated giant cells result from Toll-like receptor-induced DNA damage and cell
autonomous cell cycle modiﬁcations. However, the giant cell progenitor identity remained
unclear. Here, we show that the giant cell-forming potential is a particular trait of monocyte
progenitors. Common monocyte progenitors potently produce cytokines in response to
mycobacteria and their immune-active molecules. In addition, common monocyte progenitors accumulate cholesterol and lipids, which are prerequisites for giant cell transformation.
Inducible monocyte progenitors are so far undescribed circulating common monocyte progenitor descendants with high giant cell-forming potential. Monocyte progenitors are induced
in mycobacterial infections and localize to granulomas. Accordingly, they exhibit important
immunological functions in mycobacterial infections. Moreover, their signature trait of high
cholesterol metabolism may be piggy-backed by mycobacteria to create a permissive niche.
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T

he development of the Homo sapiens sapiens has been in
coevolution with mycobacteria. It can be safely assumed
that this process is ongoing, since even in highly developed
countries, humans are exposed to mycobacteria on a daily basis.
Environmental mycobacteria with potential virulence for humans
such as Mycobacterium avium are regularly found in drinking
waters1,2. Moreover, an estimated 2 billion people worldwide are
infected with M. tuberculosis (M.tb)3 and most of these infections
are latent, i.e. asymptomatic4. In other words, tight immunological control is essential to prevent the individual from succumbing to mycobacterial infection, even after decades of
coexistence5. A well-appreciated site of mycobacterial latency is
the unique multicellular granuloma reaction6. Distinct types of
macrophages (MΦ), particularly multinuclear giant cells (MGC),
contribute to the core of granulomas. Although the ﬁrst
description of MGC in tuberculous granuloma was published 150
years ago7 and their origin from leukocytes has long been
postulated8, mechanisms underlying mycobacterial MGC formation have still been incompletely resolved. We have recently
shown that the development of polyploid MGC involves cellautonomous afﬂiction of DNA damage and impairment of p53
function by the potent antimycobacterial effector nitric oxide
(NO), resulting in mitotic defects and multinucleation9,10. Thus,
much enlarged MΦ that avidly phagocytose mycobacteria and
infected apoptotic cells arise9,10. However, mycobacteria may
override the antibacterial activity of MGC, turning them into
dedicated mycobacterial niches within the human host10. Despite
the striking cell biological properties of MGC, their origin
remains poorly understood. Dissection of the MGC pedigree
seems particularly important, regarding the recent revolution in
understanding MΦ development. In particular, it remains to be
resolved, if MGC are the progeny of a speciﬁc cell lineage or
subset, and what metabolic preconditions might determine the
differentiation path towards an MGC. Mononuclear phagocytes,
i.e., monocytes, MΦ, and dendritic cells (DC) share a common
progenitor, the monocyte-MΦ-DC progenitor (MDP)11,12,
although recent data rather indicate that MDP and GMP constitute independent progenitors of monocytes13. The position of
MDP in deﬁnitive hematopoiesis is based on experimental data
from mice and receives further support by the recent identiﬁcation of the human MDP analogue14. An even more committed
clonogenic common monocyte progenitor (cMoP), which renews
monocytes and MΦ independently of DC, has been identiﬁed in
the bone marrow and spleen of mice15, as well as in human bone
marrow and umbilical cord blood16. Whereas the role of cMoP to
monocyte and MΦ development is well established, biological
functions beyond myeloid cell development have not been
assigned to cMoP, yet.
Here, we introduce cMoP and its progeny, the circulating
inducible monocyte progenitor (iMoP) as immune cells with a
particular capacity for MGC transformation. The high cholesterol
and lipid metabolism in cMoP is an essential prerequisite for
MGC formation and may favor intracellular mycobacterial survival, since cholesterol serves as an energy source for M.tb17.
Together, we provide ﬁrm evidence for a so far unappreciated role
of monocyte progenitors in mycobacterial infections. They inextricably integrate progenitor characteristics, such as high proliferative activity and low apoptosis, with speciﬁc functions in
mycobacterial immunity.
Results
cMoP are dedicated progenitors for multinucleated giant cells.
We previously found that MΦ progenitors have a higher
potential than mature MΦ to undergo transformation into MGC
upon infection with mycobacteria or TLR2 stimulation (Fig. 1a
2

and Herrtwich et al.)9. However, since the progenitor characteristics remained undeﬁned, we decided to systematically
explore the identity of the MGC progenitor. Thus, we stringently
sorted monocytes (MC), cMoP, MDP, and Lin− c-kit+ progenitors from the bone marrow of Cx3cr1gfp/+ reporter mice
(Fig. 1b). In agreement with the most widely accepted deﬁnitions (Auffray et al.)11, (Hettinger et al.)15, we identiﬁed MDP as
CD11b− CD117+ CD115+ CX3CR1+ Ly6C−. cMoP differed
from MDP with respect to Ly6C expression (CD11b− CD117+
CD115+ CX3CR1+ Ly6C+)15. MC were deﬁned as CD11b+
CD117− CD115+ CX3CR1+, and Lin− c-kit+ progenitors as
CD11b− CD117+ CD115− (Fig. 1c). The primary and most
robust endpoint was the formation of MGC, which were deﬁned
as cells with at least three nuclei and an increased cytoplasmic
area (Fig. 1a). Using this deﬁnition, cMoP exhibited an
exceedingly high ability to form MGC in response to the
mycobacterial glycolipid lipomannan (LM). Multinucleation and
cell surface enlargement was evident already after 4 days, and
increased further until day 6 (Figs. 1d and e). In contrast to
cMoP, the quantitative MGC formation was only marginally
above base line in MC and Lin− c-kit+ cells under the same
conditions (Fig. 1e). The recently disputed cMoP progenitor
MDP18 showed some, albeit delayed and overall reduced capacity to form MGC, compared to cMoP (Fig. 1e). The high MGCforming potential of cMoP was conﬁrmed by in vitro infection
with the M.tb-complex species M. bovis Bacillus CalmetteGuérin (BCG) (Fig. 1f and Supplementary Figs. 1a and 1b).
Under all these conditions, cMoP were not only potent, but also
quite speciﬁc MGC progenitors, since besides absolute quantity,
the relative proportion of cMoP-derived MGC was also
increased compared to MC (Figs. 1d, g and Supplementary
Fig. 1c). In extension of our relatively stringent deﬁnition of
MGC as cells with at least 3 nuclei, we wondered if binucleation
may serve as a marker for the transformation process into MGC.
Indeed, we observed an absolute predominance of binucleated
cells in cMoP compared to MC after exposure to BCG (Supplementary Fig. 1c). Yet, the total number of cells with two
nuclei was highest in cMoP treated with M-CSF alone (Supplementary Fig. 1d). This was likely due to the complex balance
of binucleated cells as an indicator of high multiplication rates,
which resolves upon further proliferation (M-CSF control), and
binucleation as an indicator of mitotic defects promoting polyploidy and multinucleation (BCG stimulation). More immature
progenitors as MDP responded to stimulation with mycobacterial glycolipids predominantly with proliferation into
mononuclear daughter cells (Supplementary Fig. 1e). Similar to
monocytes from the bone marrow (MC), blood monocytes did
not show MGC-forming properties, when stimulated with LM
(Fig. 1g and Supplementary Fig. 1f).
cMoP combine macrophage and progenitor characteristics. In
full agreement with their progenitor status and similar to previously published data15, cMoP showed rapid proliferation with
total CFSE dilution already after 3 days in vitro (Fig. 2a). Stimulation with LM markedly decreased proliferation over the
entire course of the experiment (Fig. 2b). These observations
were conﬁrmed by analysis of the cell density after stimulation
with ﬁxed M. bovis BCG (Fig. 2c). Next, we determined, whether
cMoP differed from MC in their cell death response to mycobacteria. We found increased apoptosis in MC compared to
cMoP, when stimulated with ﬁxed M.tb (Fig. 2d). In line with
these observations, MC stimulated with BCG showed a decreased
mitochondrial potential compared to cMoP, which is indicative
of apoptosis (Supplementary Fig. 1g). Accordingly, viability of
cMoP exposed to mycobacteria and their glycolipids exceeded
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that of MC. Since cMoP were highly activated by the Toll-like
receptor (TLR) 2 agonist LM (Fig. 1e), we wondered whether
cMoP differed from other myeloid cell subsets in regard to TLR
expression. Notably, we found cMoP to express TLR2 and TLR6,
the cognate receptors of diacylated glycolipids19. In contrast, the
expression of TLR13, the receptor for bacterial RNA, was very
low in cMoP, yet high in MC (Fig. 2e). Since MDP and MC
showed similar or higher expression of TLR2 and TLR6 than
cMoP, we concluded that TLR expression was probably not a
limiting factor in MGC formation by MC (Fig. 2e). These
observations, together with those on survival and the superior
MGC-forming properties of cMoP in the presence of mycobacteria, spurred the hypothesis that cMoP may be important in

ARTICLE

mycobacterial immunity. Thus, we measured induction of TNFα
formation and nitric oxide (NO) as established components of
mycobacterial immunity and found cMoP to be highly active for
both parameters (Figs. 2f and g). High NO activity was of particular interest, since we previously found it to be one of the
drivers of MGC formation via induction of DNA damage and
impairment of p5310. In full accordance with a central role of NO
in the mycobacterial response of cMoP, LM and BCG-induced
MGC formation was abrogated in cMoP from inducible nitric
oxide synthase-deﬁcient (inos−/−) mice (Fig. 2h). Altogether,
cMoP showed characteristic progenitor traits of high proliferative activity combined with signature properties for mycobacterial immunity.
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Fig. 1 cMoP are dedicated progenitors for multinucleated giant cells. a Phalloidin (green) and Hoechst (blue) staining of a cMoP-derived MGC after
stimulation with BCG-RFP (red). Scale bar: 20 µm. Channels were adjusted individually with respect to contrast and brightness. b Scheme of monocyte/
macrophage cell development in murine bone marrow (BM). c FACS gating for sorting of cMoP, MDP, Lin− c-kit+ cells and MC from bone marrow of
Cx3cr1gfp/+ mice. d Representative Hemacolor stainings of cMoP from Cx3cr1gfp/+ mice, stimulated with LM (Lipomannan from M. smegmatis, 4 µg/ml) for
2 or 6 days compared to M-CSF (50 ng/ml) controls. Scale bar: 100 µm. Gamma-correction was adjusted to 0.8 in all images. e cMoP (dark blue), MDP
(cyan, dashed), Lin− c-kit+ cells (gray, dashed) and MC (light blue) were stimulated with LM (4 µg/ml) for 2, 4, and 6 days. Quantiﬁcation of MGC per
cm2 based on Hemacolor staining (compare Fig. 1d). Depicted are mean ± SEM of n = 3 (MDP D2 and D4), n = 4 (MDP D6), n = 4 (cMoP, MC, Lin− c-kit+
D2 and D4) and n = 6 (cMoP, MC, Lin− c-kit+ D6) biologically independent samples. ****p < 0.0001 (cMoP – MDP), ####p < 0.0001 (refers to MC and
Lin− c-kit+); (two-way ANOVA, Tukey’s multiple comparisons test (MCT)). f cMoP (dark blue), MDP (cyan), Lin− c-kit+ cells (gray) and MC (light blue)
from Cx3cr1gfp/+ mice were stimulated with LM (4 µg/ml) or BCG (MOI 20, MOI 100) for 6 days and quantiﬁed for MGC formation by Hemacolor staining.
Bars show mean ± SEM of n = 13–15 (control), n = 4–6 (LM), n = 5–7 (BCG MOI 20) and n = 4 (BCG MOI 100) biologically independent samples
examined over 3–9 experiments. Detailed numbers of samples (n) for each condition are presented in Supplementary Table 3. ns = not signiﬁcant, ***p =
0.0003, ****p < 0.0001 (two-way ANOVA, Dunnett’s MCT). g Ly6C+ and Ly6C− blood monocytes (black) and BM-derived cMoP (dark blue) and MC
(light blue) were stimulated with LM (4 µg/ml) for 6 days. MGC formation was quantiﬁed based on Hemacolor staining. Graph shows mean ± SEM of n =
11 biologically independent samples for cMoP and MC, and n = 2 biologically independent samples for blood monocytes. ****p < 0.0001 (student’s
unpaired t-test, two-tailed).

cMoP-derived MΦ keep their potential to form MGC and show
a characteristic metabolic proﬁle. cMoP are an intermediate state
between the multipotent progenitors for mononuclear phagocytes
and monocytes. In view of the distinct immune cell functions of
cMoP, we analyzed the transformation kinetics of cMoP in culture. We found the cMoP immunophenotype to be very transient,
since already after 4 h in vitro almost two thirds of cMoP were
negative for the progenitor marker CD117. In contrast, CD11b
expression increased more slowly, with ~50% of cMoP expressing
CD11b at 12 h, and thus acquired an immunophenotype reminiscent of monocytes (CD11b+ Ly6C+ CD117−), (Fig. 3a and
Supplementary Fig. 2a). Stimulation with LM did not impact on
the loss of CD117 expression, yet resulted in faster upregulation of
CD11b (Supplementary Fig. 2b). After 48 h in culture with MCSF, cMoP could no longer be distinguished in ﬂow cytometry
from monocyte-derived macrophages with respect to the typical
MΦ-surface markers CD11b and F4/80 (Fig. 3b).
These ﬁndings resulted in the conundrum that cMoP, which
rapidly acquired a monocyte immunophenotype in vitro, but not
MC, were capable of transforming into MGC. Thus, we asked,
whether cMoP retained the MGC-forming capability, even when
the expression of identity-deﬁning surface markers had turned
into that of inﬂammatory monocytes. To address this question,
we cultured cMoP in M-CSF for 48 h, which resulted in an early
macrophage phenotype as outlined above (Fig. 3b), and then
added LM for 4 days. Subsequently, we determined MGC
formation and compared this with MGC generated from cMoP,
which were stimulated with LM for 4 days directly after sorting.
Intriguingly, both preparations did not quantitatively differ in
giant cell formation (Fig. 3c). These observations indicated that
surface marker expression alone was not sufﬁcient to predict the
MGC-forming potential of MΦ species. Therefore, we analyzed
the transcriptional program of cMoP, MC, and their respective
descendants after 48 h of in vitro differentiation. We cultured
cMoP and MC in M-CSF only, or additionally with LM for 48 h, a
time point when both cell types became very similar with respect
to the expression of CD117, CD11b, and Ly6C. Notably, after 48
h most of the cells originating from cMoP or MC expressed F4/
80, thereby qualifying as in vitro generated MΦ (Fig. 3b).
Transcriptomic analysis revealed a multitude of differentially
regulated genes between cMoP and MC after LM stimulation
(Supplementary Figs. 2c and 2d). In particular, MC downregulated genes of key enzymes for cholesterol and fatty acid
metabolism upon TLR2 activation (Fig. 3d). In contrast, the
respective lipid metabolism genes were not downregulated when
cMoP were stimulated in a similar fashion, indicating that
metabolic changes were connected with MGC transformation.
4

Yet, the expression of the dehydrocholesterol reductase 24, which
catalyzes the production of cholesterol from desmosterol20, as
well as HMG-CoA-reductase, the rate-limiting enzyme for
cholesterol synthesis and squalene epoxidase21, were upregulated
in LM-stimulated cMoP compared to LM-stimulated MC (Figs. 3d
and e). Corresponding to this, Msmo1 and Lss, two genes
involved in steroid metabolism and terpenoid backbone
biosynthesis22, were upregulated in LM-stimulated cMoP
(Fig. 3d). The same regulatory mechanisms were observed for
key enzymes of fatty acid synthesis, such as fatty acid synthase
and fatty acid desaturase (Figs. 3d and e). In contrast, the
carnitine o-palmitoyltransferase 1, which mediates β-oxidation23
and therefore degradation of fatty acids, was transcriptionally
downregulated in activated cMoP compared to MC. In addition,
lipid binding molecules and transporters were differentially
regulated in cMoP and MC (Fig. 3d and Supplementary Fig. 2e).
Pathway analysis also revealed an upregulation of cholesterol
biosynthesis in cMoP stimulated with LM compared to similarly
treated MC. In contrast, the latter showed an upregulation of
apoptosis signaling, toll receptor signaling, and chemokine/
cytokine-mediated inﬂammatory signaling (Fig. 3f). Together,
these ﬁndings linked the regulation of lipid metabolism to MGC
formation, and in particular to the transformation potential
of cMoP.
Cholesterol is an integral component of cell membranes
and cholesterol synthesis is therefore essential in single-cell
growth and proliferation 20. High cholesterol metabolism in
cMoP corresponded to their strong proliferative activity
(Fig. 2a), as determined by the CFSE assay. In line with this,
we found upregulation of the proliferation marker Mki-67 in
cMoP with, and without LM stimulation, compared to MC
(Supplementary Fig. 2f).
Further differences in lipid biosynthesis between cMoP and MC
concerned prostaglandins, which are well-established intermediates in the regulation of acute and chronic inﬂammation24.
Whereas Ptges, Ptgs1 and Ptgs2, which encode for enzymes in
prostaglandin H2 and E2 biosynthesis, were upregulated in
stimulated MC as compared to cMoP, Hpgds, which is involved
in prostaglandin D synthesis, was increased in cMoP (Fig. 3d).
Differences in the expression of inﬂammatory effector molecules
are further signs of discrete immune regulator properties of these
cells. In LM-stimulated MC, genes encoding for interleukins like
IL-1β and chemokines like Cxcl3, Cxcl2, and Ccl5 (Supplementary
Figs. 2g and h) were upregulated. In cMoP, chemokines such as
Ccr5, Ccl8, and Ccl12 were potently induced by LM (Supplementary Fig. 2h). Since chemokine and interleukin production are
essential for the immune response to mycobacteria25, the contrast
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Fig. 2 cMoP combine macrophage and progenitor characteristics. a cMoP from WT mice were stained with CFSE and stimulated with lipomannan from
M. smegmatis (LM, 4 µg/ml), followed by FACS analysis after 5 h (D0, dark green), 3 days (D3, green) and 6 days (D6, light green). b Proliferation index
i
 i 
∑ N2ii with i = generation number and N = number of cells in generation i. Bars
based on CFSE staining (Fig. 2a) was determined as PI ¼ ∑ i  N2ii
1

1

show mean ± SEM of n = 3 biologically independent samples. *p < 0.05, **p = 0.0028, ***p = 0.0007 (two-way ANOVA, Tukey’s MCT). c Cell density of
cMoP from Cx3cr1gfp/+ mice stimulated with heat-ﬁxed (hf) BCG (106/ml) compared to M-CSF control (-) for 6 days determined with FACS counting
particles. Bars show mean ± SEM of n = 12 biologically independent samples examined over four experiments. **p = 0.0049 (student’s unpaired t-test,
two-tailed). d cMoP and MC from WT mice were stimulated for 6 days with hf M.tb (50 µg/ml) and stained with propidium iodide to quantify the
percentage of apoptotic cells in SubG1 phase. Staurosporine (1 µg/ml) added 6 h prior to analysis served as positive control. Depicted are mean ± SEM of
n = 5 biologically independent samples. **p < 0.01 (two-way ANOVA, Tukey’s MCT). e Tlr2, Tlr6, Tlr13 mRNA expression levels in BM precursors relative to
Gapdh. Shown are mean ± SEM of n = 4 (Lin- c-kit+, MDP, cMoP, MC Tlr2) or n = 3 (MC Tlr6 and Tlr13) biologically independent samples. f TNFα
production of BM precursors from Cx3cr1gfp/+ mice after LM stimulation (4 µg/ml) for 5 h. Depicted are mean ± SEM of n = 5 biologically independent
samples. ***p = 0.0005 (MDP), ***p = 0.0003 (cMoP), (two-way ANOVA, Sidak’s MCT). g Representative histogram and quantiﬁcation of intracellular
iNOS staining in cMoP from Cx3cr1gfp/+ mice, stimulated with BCG (MOI 20) for 8 days. Depicted are mean ± SEM of n = 4 biologically independent
samples examined over two experiments. ****p < 0.0001 (student’s unpaired t-test, two-tailed). h Quantiﬁcation of MGC formation by cMoP from inos−/−
after LM stimulation (4 µg/ml) or BCG (MOI 100) for 6 days. Depicted are mean ± SEM of n = 5 (-) or n = 3 (LM, BCG) biologically independent samples.
ns = not signiﬁcant (one-way ANOVA, Dunnett´s MCT).

between cMoP and MC with respect to their transcriptomes might
also be connected with their differences in longevity, cell death,
and transformation into MGC.
Cholesterol and fatty acid biosynthesis are essential for MGC
formation. In order to dissect the role of lipid and cholesterol
metabolism in the formation of MGC, we performed staining
with the cholesterol and lipid dye ﬁlipin in MGC from cMoP
infected with BCG-RFP. We observed the accumulation of cholesterol/lipids in MGC (Fig. 4a). Filipin staining in ﬂow cytometry
revealed that cMoP had a signiﬁcantly faster accumulation of

cholesterol/lipids upon stimulation with ﬁxed BCG compared to
MC, i.e., already after 2 days (Fig. 4b).
In addition, we quantiﬁed the cholesterol content in cMoP with
the ﬂuoremetric amplex red assay. We found higher cholesterol
concentrations in cMoP infected with BCG as compared to
resting cMoP (Supplementary Fig. 3a), highlighting a net
upregulation of cholesterol synthesis as a consequence of the
transcriptional changes in fatty acid and cholesterol producing
metabolic pathways (Figs. 3d and e). Lipid accumulation,
however, requires that the cellular export systems are not
upregulated in parallel to biosynthesis. The transcriptomes of
resting and stimulated cMoP did not unveil downregulation of
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Abcg1 and Abca1, genes coding for the two main cholesterol
transporters (Fig. 3d). However, this analysis was performed 48 h
after induction of the MGC transformation, i.e., before MGC
have fully developed (compare Fig. 1d). In order to complement
this analysis, mRNA expression levels of Abca1 and Abcg1 were
established 6 days following differentiation. At this time point
these genes were downregulated in cMoP-derived MGC (Fig. 4c).
Accordingly, it seemed safe to conclude that the accumulation of
cholesterol/lipids originated from dysregulated metabolic pathways and, additionally, a reduction in cholesterol and triglycerides efﬂux. We tested whether cholesterol accumulation was,
besides being a signature trait of cMoP, causally linked to the
6

MGC transformation process. Accordingly, we interfered with the
cholesterol metabolism in MGC during the transformation
process and analyzed the effect on the phenotype. First, we
employed cholesterol oxidase, a ﬂavoenzyme that associates with
lipid bilayers, binds cholesterol and desorbs it from the
membrane. Coincubation of cMoP with cholesterol oxidase
during the transformation process decreased MGC formation
by about 50% when stimulated with live or ﬁxed bacteria (Fig. 4d
and Supplementary Fig. 3b). In addition, cholesterol was
extracted from the cells with methyl-β-cyclodextrin (MBCD),
which facilitates the efﬂux of cholesterol by complexing and
solubilizing the lipids26. In line with the effects of cholesterol
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Fig. 3 cMoP-derived MΦ keep their potential to form MGC and show a characteristic metabolic proﬁle. a Dot plot of cMoP analyzed immediately after
isolation for initial surface marker expression. Surface marker expression of cMoP and MC from Cx3cr1gfp/+ mice analyzed by FACS related to CD45+ cells
after 4, 8, 12 or 48 hours in culture with M-CSF. Depicted are mean ± SEM of n = 3–4 (CD117), n = 5–9 (CD11b), n = 3–5 (F4/80) biologically independent
samples. Detailed sample numbers (n) are presented in Supplementary Table 4. ns = not signiﬁcant, *p = 0.0161, ***p = 0.0009 (CD117), ***p = 0.0005
(CD11b), ****p < 0.0001 (two-way ANOVA, Sidak’s MCT). b Representative FACS dot plots for F4/80 and CD11b expression of cMoP and MC after 48 h in
medium supplemented with M-CSF. c cMoP or MC from Cx3cr1gfp/+ mice were stimulated either directly with LM (4 μg/ml) for 4 days or after 2 days in
culture with M-CSF (cond-cMoP, cond-MC). MGC formation was quantiﬁed based on Hemacolor stainings (scale bar: 100 µm). Bars show mean ± SEM of
n = 4 (cMoP) and n = 3 (MC) independent biological samples. ns = not signiﬁcant (cMoP — cond-cMoP: p = 0.8162; MC — cond-MC: p = 0.9942), *p =
0.0256 (cMoP — MC), *p = 0.0109 (cond-cMoP — cond-MC), (one-way ANOVA, Tukey’s MCT). d Heatmaps of gene expression in cMoP and MC from
Cx3cr1gfp/+ mice after LM stimulation (4 µg/ml, 48 hours) with M-CSF (50 ng/ml). M-CSF alone served as control (-). Depicted are standardized log2
differences of signiﬁcantly up- (red) or downregulated (blue) genes in cMoP-LM compared to MC-LM or cMoP (-) compared to MC (-). The analysis was
performed with two biologically independent samples per group (1 = sample 1; 2 = sample 2) by gene-ontology terms (GO-Terms), (GO:0006631 fatty
acid metabolic process, GO:0008203 cholesterol metabolic process, GO:0001516 prostaglandin biosynthetic process, GO:0006694 steroid biosynthetic
process, GO:0006869 lipid transport). If GO-Terms overlapped, respective genes were only assigned to one group. e Dhcr24 and Fasn mRNA expression
levels relative to Gapdh in cMoP and MC, stimulated with LM (12 µg/ml, light gray, diamonds) for 48 h compared to M-CSF control (dark gray, triangles)
determined by qRT-PCR. Bars show mean ± SEM of n = 3 biologically independent samples. **p = 0.0015 (Dhcr24), **p = 0.0091 (Fasn), ***p = 0.0005
(two-way ANOVA, Sidak’s MCT). f Panther pathway analysis of gene expression data described in Fig. 3d. Depicted are signiﬁcantly up- (red) or
downregulated (blue) pathways in cMoP-LM versus MC-LM.

Fig. 4 Cholesterol metabolism is an essential prerequisite for MGC formation. a Filipin (blue) and wheat germ agglutinin (WGA, green) staining of
cMoP-derived MGC induced with heat-ﬁxed (hf) BCG (106/ml) and additionally infected with BCG-RFP (MOI 1, red). Scale bar: 20 µm. Representative
staining out of three independent experiments shown. Channels were adjusted individually with respect to contrast and brightness. b Filipin staining,
depicted is the mean ﬂuorescence intensity (MFI) of cMoP (blue) and MC (green) from Cx3cr1gfp/+ mice stimulated with hf BCG (106/ml) (treatment)
normalized to M-CSF control at day 2. Shown are mean ± SEM of n = 8 biologically independent samples examined over three experiments. ****p < 0.0001
(student´s unpaired t-test, two-tailed). c Abcg1 and Abca1 mRNA expression levels relative to Gapdh mRNA of cMoP stimulated with heat-ﬁxed M.tb
(50 µg/ml) for 6 days determined by qRT-PCR. Bars show mean ± SEM of n = 5 biologically independent samples. **p = 0.0099 (Abcg1), **p = 0.0095
(Abca1), (student´s unpaired t-test, two-tailed). d cMoP from Cx3cr1gfp/+ mice were stimulated with BCG (MOI 20), heat-ﬁxed BCG (106/ml) or heat-ﬁxed
M.tb (10 µg/ml) and treated with cholesterol oxidase (2 mU/ml, beige) or PBS (vehicle, blue) for 6 days. MGC quantiﬁcation by Hemacolor staining. Bars
show mean ± SEM of n = 17 (-), n = 9 (BCG), n = 15 (BCG hf), n = 12 (M.tb) independent biological samples examined over 11 experiments. ns = not
signiﬁcant (p = 0.9504), *p = 0.0251, **p = 0.0052, ***p = 0.0004 (two-way ANOVA, Sidak’s MCT). e cMoP from Cx3cr1gfp/+ mice stimulated with heatﬁxed BCG (106/ml) or heat-ﬁxed M.tb (10 µg/ml) and treated with methyl-β-cyclodextrin (MBCD, 1 mmol, beige) or dH2O (vehicle, blue) for 6 days. MGC
quantiﬁcation by Hemacolor staining. Bars show mean ± SEM of n = 20 (-), n = 8 (BCG), n = 7 (M.tb) biologically independent samples. **p = 0.0038,
****p < 0.0001 (two-way ANOVA, Sidak’s MCT). f cMoP from Cx3cr1gfp/+ mice were stimulated with heat-ﬁxed M.tb (10 µg/ml) and treated with methylβ-cyclodextrin (MBCD, 1 mmol), LDL (50 µg/ml) or PMA (1 µg/ml) for 6 days. Vehicle control for MBCD was dH2O. Bars show mean ± SEM of n = 15
biologically independent samples in seven experiments (M-CSF control) and n = 7 biologically independent samples in three experiments (M.tb). *p < 0.05,
***p = 0.0004, ****p < 0.0001 (one-way ANOVA, Tukey’s MCT).
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Fig. 5 Altering fatty acid metabolism by orlistat affects MGC formation. a cMoP from Cx3cr1gfp/+ mice were stimulated with BCG (MOI 20), heat-ﬁxed
BCG (106/ml), heat-ﬁxed M.tb (50 µg/ml) and treated with orlistat (100 µmol, beige) or vehicle control (ethanol, blue) for 6 days. MGC were quantiﬁed by
Hemacolor staining (scale bar: 100 µm). Gamma-correction was adjusted to 0.45 in both images. Bars depict mean ± SEM of n = 3 (BCG, BCG hf) and n =
4 (control, M.tb) biologically independent samples. ns = not signiﬁcant (p = 0.1532), **p = 0.0022, ****p < 0.0001 (two-way ANOVA, Sidak’s MCT).
b Hoechst staining of cMoP from Cx3cr1gfp/+ mice stimulated with BCG (MOI 20) and treated with orlistat (100 µmol) or ethanol (control) for 6 days.
MGC were quantiﬁed as polyploid cells (N > 4) from histogram peaks. Bars show mean ± SEM of n = 3 biologically independent samples. **p < 0.01 (oneway ANOVA, Tukey’s MCT). c Cell density determined by FACS counting particles of cMoP from Cx3cr1gfp/+ mice treated as indicated in Fig. 5b. Bars
show mean ± SEM of n = 5 biologically independent samples. d TNFα production of cMoP from Cx3cr1gfp/+ mice treated as indicated in Fig. 5b. LPS
(100 ng/ml) was added 5 h prior to analysis. Bars show mean ± SEM of n = 3 biologically independent samples. ****p < 0.0001 (one-way ANOVA, Sidak’s
MCT). e Sterol analysis of cMoP (blue) and MC (green) from Cx3cr1gfp/+ mice stimulated with heat-ﬁxed BCG (106/ml, squares) for 6 days compared to
M-CSF (50 ng/ml, circles) control (-). Shown are cholesterol, desmosterol, and 7-dehydrocholesterol (7-DHC) content normalized to cell number.
Depicted are mean ± SEM of n = 4 biologically independent samples (cMoP control with n = 3 as one sample could not be analyzed for technical reasons).
*p = 0.0195, **p = 0.0019 (desmosterol), **p = 0.002 (7-DHC, BCG), **p = 0.0063 (7-DHC, control), ***p = 0.0001, ****p < 0.0001 (two-way ANOVA,
Tukey’s MCT). f Sqle, Dhcr24, Hmgcr and Fasn mRNA expression levels of cMoP and MC stimulated with heat-ﬁxed BCG (106/ml, diamonds, hatched bars)
for 6 days relative to Gapdh compared to M-CSF (50 ng/ml) controls (circles, gray bars). Bars show mean ± SEM of n = 5 biologically independent samples
in two experiments. *p = 0.0328 (Fasn), *p = 0.0155 (Hmgcr, cMoP-control — cMoP-BCG), *p = 0.0313 (Hmgcr, MC-control — cMoP-BCG), **p = 0.0057
(Sqle), **p = 0.0013 (Dhcr24), **p = 0.001 (Hmgcr), **p = 0.0016 (Fasn), ***p = 0.001, ****p < 0.0001 (two-way ANOVA, Tukey’s MCT).

oxidase, MBCD substantially inhibited MGC formation (Fig. 4e
and Supplementary Fig. 3c). We then employed the reverse
approach by adding human low-density lipoproteins (LDL) to the
culture. In order to facilitate the uptake of LDL, PMA was
added27. Using this approach, we found LDL donation to rescue
MGC formation in MBCD treated cells (Fig. 4f and Supplementary Fig. 3d). As a complementary approach, we used tetrahydrolipstatin (orlistat), which irreversibly inhibits the fatty acid
synthase28 and prevents triacylglycerol degradation29. In full
support of the model that lipid provision is rate limiting for the
MGC transformation process by cMoP, we found orlistat to
inhibit MGC formation in response to ﬁxed and live mycobacteria (Fig. 5a). Orlistat reduced the total number of nuclei per
MGC and the percentage of polyploid cells (N > 4) (Fig. 5b).
8

Moreover, orlistat prevented the foamy, lipid-rich cytoplasmic
appearance and conserved relatively small MΦ with several
pseudopodia (Fig. 5a). Since interfering with lipid metabolism is
potentially impacting on cell viability, we carefully assessed any
toxic effects of cholesterol oxidase, MBCD and orlistat. We found
that cMoP incubated with BCG and orlistat proliferated more
than cMoP treated with BCG alone and were similar to untreated
control cells in this respect (Fig. 5c). In full agreement, orlistat
treated cells did not differ from untreated cells with respect to
TNFα formation in response to LPS (Fig. 5d). Upon addition of
cholesterol oxidase, cell density and TNFα production after LPS
stimulation were not affected compared to vehicle controls
(Supplementary Figs. 3e and f). When measuring cell density for
MBCD stimulated cells, we found a reduction, when LDL was
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added additionally, which was in line with the high amount of
MGC formed under these conditions (Supplementary Fig. 3g).
The reduction in cell number upon addition of MBCD alone to
M.tb stimulated cMoP (Supplementary Fig. 3g) was likely due to
the reduced availability of cholesterol for membrane formation
and proliferation. The efﬁcacy of MBCD to extract cholesterol
from the cells was examined by ﬁlipin staining (Supplementary
Fig. 3h). Similar to cholesterol oxidase and orlistat, MBCD did
not impact on the TNFα response to LPS (Supplementary Fig. 3i).
Together, these ﬁndings suggested that blocking of the fatty acid
synthase and depriving the cells of cholesterol inhibit the MGC
transformation process driven by mycobacteria, and conserves
the mononuclear MΦ state. Next, we dissected the differences in
lipid composition of BCG-stimulated cMoP and MC by liquid
chromatography-mass spectrometry-based sterol analyses. After
6 days of BCG stimulation, we found cholesterol accumulation in
both cMoP and MC. However, the accumulation of cholesterol
precursors signiﬁcantly differed in these cell types. BCGstimulated cMoP showed an increase in desmosterol content, in
contrast to MC, which rather contained 7-dehydrocholesterol (7DHC) (Fig. 5e and Supplementary Fig. 3j). Both sterols are
precursors of cholesterol. Desmosterol is formed via the Bloch
pathway, and 7-DHC via the Kandutsch-Russell pathway30.
Previously, the accumulation of desmosterol was reported to be
characteristic for foam cell transformation in atherosclerosisassociated MΦ31. Furthermore, an immunomodulatory function
was described for speciﬁc cholesterol precursor derivatives32.
Accordingly, the accumulation of different cholesterol precursors
in BCG-stimulated cMoP and MC indicated that cholesterol
metabolism was differentially regulated in these subsets. In order
to explore, whether cMoP keep cholesterol biosynthesis upregulated during the entire transformation process into MGC, we
analyzed the expression of key enzymes of the cholesterol and
fatty acid biosynthesis. We found upregulation of Sqle, Dhcr24,
Hmgcr, Fasn, Acat2, and Cyp51 in BCG-stimulated cMoP in
contrast to MC (Fig. 5f and Supplementary Fig. 3k). However, the
expression of Acat1 involved in β-oxidation and the degradation
of fatty acids was downregulated in stimulated cells (Supplementary Fig. 3k). In addition, the upregulation of cholesterol
biosynthesis in cMoP-derived MGC in contrast to monocytes
was in line with the transcriptome analysis for LM-stimulated
cMoP (Fig. 3f).
In order to further dissect the intrinsic metabolic signature in
MGC, we analyzed the glycolytic phenotype in cMoP-derived
MGC using an extracellular ﬂux analyzer. MGC showed a higher
extracellular acidiﬁcation rate in glycolysis stress tests than
control cells (Supplementary Fig. 4a), as well as a signiﬁcant
upregulation of glycolysis. This indicated that in addition to fatty
acid and cholesterol metabolism, glycolysis plays an important
role in MGC transformation, which hints at high ATP
consumption requirements. These observations are in full
accordance with a decrease in MGC formation in the presence
of 2-deoxy-D-glucose (2-DG), a competitive inhibitor of
glycolysis (Supplementary Fig. 4b). Since the target of rapamycin
(mTOR) has previously been implicated in the switch from
oxidative phosphorylation to glycolysis in DC33, we tested the
impact of rapamycin on MGC formation and found a decrease of
MGC transformation in cMoP (Supplementary Figs. 4c and d).
Together, these ﬁndings emphasize the close interaction between
the immune response to mycobacteria/TLR2 ligands and
metabolic changes in cMoP.
iMoP — a circulating monocyte progenitor in M.tb infection.
After establishing the high potential of cMoP to form MGC, we
set out to deﬁne their role in vivo. We employed two different
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mouse models for pulmonary tuberculosis. Aerogenic exposure to
a low-dose inoculum of virulent M.tb results in progressive disease, with a peak of infection after 21 days, in both the resistant
mouse strain C57BL/6 and in the susceptible strain 129S2.
Whereas C57BL/6 mice survive and develop a chronic infection,
129S2 mice succumb to infection within 5 weeks and mimic
active tuberculosis in humans34,35. In both mouse strains, we
found increased frequencies of cMoP in the bone marrow at day
21 post-infection. In contrast, cMoP were hardly detectable in the
blood during tuberculosis progression (Fig. 6a). We postulated
that cMoP undergo early changes with respect to their cell surface
marker expression, similar to our in vitro observations (Fig. 3a).
In line with this assumption, we identiﬁed a circulating cell
population that differed from cMoP only with respect to CD117
expression (Fig. 6b). This cell type, which we denominated
induced monocyte progenitors (iMoP), fully correlated with the
differentiation phenotype of cMoP in vitro, where 70% of cells
lost CD117 expression within 4 hours. Similar to cMoP, we found
iMoP to be present in the bone marrow of uninfected mice, and
an increase of iMoP frequency at day 21 in infected mice. In
contrast to cMoP, which almost exclusively reside in bone marrow and spleen, iMoP were detectable at a low frequency in
peripheral blood already in steady state. During infection, iMoP
markedly increased up to 1% of CD45-positive blood cells at day
14 and 21, especially in the susceptible 129S2 mice (Fig. 6c).
Hemacolor staining of freshly sorted progenitors showed iMoP
with decreased nucleus to cytoplasma ratio compared to MDP
and cMoP, but higher cellular granularity (Fig. 6d). We further
assessed whether iMoP retained the capacity to form MGC. We
extracted cMoP, iMoP and MC from the bone marrow of
Cx3cr1gfp/+ mice. iMoP showed an intermediate potential to
produce MGC upon exposure to both live and ﬁxed bacteria
(Fig. 6e). In contrast to MDP, which also showed an intermediate
potential to form MGC, iMoP more speciﬁcally formed multinucleated giant cells (Supplementary Fig. 5a). Furthermore iMoP,
cMoP, and MC produced TNFα within 5 h after stimulation with
ﬁxed M. bovis BCG, whereas more immature progenitors like
Lin− c-kit+ cells and MDP did not show this ability (Fig. 6f). To
further analyze the recruitment of iMoP into the blood stream, we
infected 129S2 mice with a low dose of M.tb and neutralized
CCR2-positive cells with the application of a CCR2 antibody
(MC-21) starting day 14 p.i.. Mice injected with the CCR2speciﬁc antibody showed a signiﬁcant decrease of iMoP frequency
in the BM and completely failed to mobilize iMoP into the blood
(Fig. 6g and Supplementary Fig. 5b). We also observed a signiﬁcant reduction of cMoP frequency in the BM after antibody
treatment (Fig. 6g). These results were in line with our ﬂow
cytometry analysis of CCR2 expression on the different bone
marrow progenitor subsets, where we observed increased binding
of the MC-21 antibody depending on the maturity state of the
progenitor subsets (Supplementary Fig. 5c). Injection of the
CCR2-speciﬁc antibody did not inﬂuence bacterial burdens in the
lung or spleen (Supplementary Fig. 5d). Accordingly, circulating
iMoP were not essential to control M.tb in these mouse models,
where MGC can hardly be found at the investigated time points
(Supplementary Figs. 5e, f and g). However, the spontaneous
formation of neutralizing antibodies against MC-21 antibodies in
treated mice precludes longer depletion experiments. Thus, in
order to further explore the role of CCR2 in MGC formation at
later stages of infection, we analyzed M.tb infected Ccr2−/− mice
from day 60 to day 300 p.i.. We found an increase in the total area
of inﬂammation in lungs from Ccr2−/− mice with time, which
was not visible in wild-type infected mice (Supplementary
Figs. 5e, f and g). This is compatible with the notion that circulating monocyte progenitors and/or mature monocytes contribute
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to inﬂammation control in pulmonary Tb infection. In contrast,
the relative immune cell composition was largely similar in both
mouse strains, including MGC with high lipid content and foam
cell formation after 100 and 300 days of infection (Supplementary
Fig. 5f). Of note, monocytes (and probably their precursors) are
reduced by 80–90% in Ccr2−/− mice36. Thus, the remaining
monocyte progenitors in the circulation of Ccr2−/− mice might
ﬁll the MGC progenitor niche during the mycobacterial infection,
in particular since chronic lung inﬂammation in M.tb infection is
a slow process with relatively low cell turnover. Notably, isolated
progenitors from wild-type and Ccr2−/− mice treated with heatﬁxed BCG exhibited a largely similar potential to form MGC
10

in vitro, with only a modestly reduced capacity of CCR2-deﬁcient
cMoP (Supplementary Figs. 5h and i).
In summary, we identiﬁed a circulating monocyte progenitor
subset termed iMoP, which has a high capacity to form MGC and
circulates at increased frequency in mycobacterial infection.
iMoP — a progenitor cell between cMoP and monocytes. The
surface marker expression (CX3CR1+ CD117− CD115+ Ly6C+
CD11b−) of iMoP differed from cMoP with respect to CD117
expression and from MC with respect to the lack of CD11b
expression. CD115 upregulation classiﬁed iMoP as part of the
monocyte/macrophage lineage. Since, in contrast to cMoP, iMoP
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Fig. 6 iMoP – a circulating monocyte precursor in M.tb infection. a, c Frequency of cMoP and iMoP in bone marrow (BM) and blood of mice infected via
aerosol with M.tb (H37Rv, 200 CFU) analyzed by FACS 7, 14 and 21 days post infection (p.i.). Graphs show mean ± SD of n = 8–9 mice (uninfected
controls), n = 8–10 mice (day 14, day 21) in two experiments and n = 4–5 mice (day 7) in one experiment. Detailed numbers of mice (n) for each
condition/time point are presented in Supplementary Table 5. *p = 0.0125, **p = 0.0017 (iMoP in BM), **p = 0.0022 (iMoP in blood, D14), **p = 0.0036
(iMoP in blood, D21), ****p < 0.0001 (refers to all other time points of the respective mouse line), (two-way ANOVA, Tukey’s MCT). Two outliers were
removed from iMoP in blood at day 14 C57BL/6 (2.49) and 129S2 (8.50), calculated by Grubbs test. b Flow cytometry gating of iMoP from BM of
Cx3cr1gfp/+ mice. d Hemacolor staining of murine BM precursors immediately after cell sorting. Scale bar: 50 µm. Gamma-correction was adjusted (0.53)
in all images. e MGC formation of cMoP, iMoP (red) and MC stimulated with BCG (MOI 20), heat-ﬁxed BCG (106/ml) or heat-ﬁxed M.tb (10 µg/ml) for
6 days. Bars show mean ± SEM of n = 5 (M.tb, cMoP-BCG) or n = 6 (control, BCG hf, iMoP-BCG, MC-BCG) biologically independent samples examined
over three experiments. ns = not signiﬁcant (p = 0.7241), ***p = 0.0001 (M.tb: cMoP – iMoP), ***p = 0.0009 (M.tb: MC – iMoP), ***p = 0.0004 (BCG hf:
MC – iMoP), ****p < 0.0001 (two-way ANOVA, Tukey’s MCT). f TNFα production of BM precursors from Cx3cr1gfp/+ mice after stimulation with heatﬁxed BCG (106/ml) for 5 h determined by FACS compared to M-CSF controls. Depicted are mean ± SEM of n = 6 independent biological samples examined
over two experiments. ****p < 0.0001 (two-way ANOVA, Sidak’s MCT). g M.tb aerosol infection (H37Rv, 200 CFU) of 129S2 mice, followed by
intraperitonal injection of a CCR2-speciﬁc antibody (MC-21, 20 µg daily) or isotype control (MC-67), starting on day 14 p.i.. FACS analysis of progenitor
frequency in blood and BM at day 19 p.i.. Graphs show mean ± SD of n = 10 mice per group examined over two experiments. ****p < 0.0001 (student’s
unpaired t-test, two-tailed).

were capable of circulating in the blood, we aimed to further
characterize this so far undescribed bone marrow subset and to
distinguish these cells from other progenitors. We therefore
performed a transcriptomic analysis of iMoP and cMoP, sorted
directly from murine bone marrow and found 391 genes to be
signiﬁcantly upregulated, and 260 genes to be signiﬁcantly
downregulated in iMoP as compared to cMoP (Fig. 7a). The
analysis revealed that cell cycle and cell differentiation were differentially regulated in iMoP compared to cMoP, which corresponded to their different progenitor status. Kit oncogene
(CD117) was clearly downregulated in iMoP, in line with our
previous ﬂow cytometry analysis. In contrast to this, the gene
expression of hematopoetic cell kinase (Hck), important for regulation of immune response in myeloid cells and reported to be
involved in cell recruitment to the lung and cytokine
production37, was increased in iMoP (Fig. 7b). Other genes, e.g.,
Tlr13, C3, Cd180, and Il1rn, which are involved in innate immune
response and cytokine-mediated signaling, were upregulated in
iMoP. The upregulation of Trem2, which is expressed in iMoP, is
reported to be connected with immune response to mycobacterial
infections38. This spurs the hypothesis that iMoP are involved in
mycobacterial immunity. In addition, we found differences
between iMoP and cMoP with respect to cell adhesion and cell
migration, which might explain their various potential to circulate
in the blood (Fig. 7b). Gene ontology enrichment analysis of
genes overexpressed in iMoP compared to cMoP yielded terms
such as positive regulation of monocyte chemotaxis, regulation of
inﬂammatory response and regulation of phagocytosis, which
further supported iMoP to be part of the monocyte/macrophage
lineage (Fig. 7c). Although the transcriptomic analysis indicated
an increased expression of Itgam (CD11b) in iMoP as compared
to cMoP (Fig. 7b), quantitative analysis (qRT-PCR) analysis of
sorted lineages revealed that compared to MC, iMoP were low for
Itgam, as well as Adgre1 (F4/80). For Mpo, Tlr13 and Msr1, iMoP
showed intermediate expression levels compared to cMoP and
MC (Fig. 7d). These results are in line with our hypothesis that
iMoP represent a circulating monocyte progenitor subset, which
originates in the bone marrow. In contrast to cMoP, iMoP did not
form colonies in MethoCult assay. Instead, they rather formed
groups of 2–3 cells, indicating that they lost their stem cell
potential and only undergo a limited number of divisions
(Fig. 7e). We further analyzed the capacity of the different subsets
to kill intracellular bacteria and found more live BCG in MC as
compared to cMoP and iMoP 4 days post infection (Supplementary Fig. 5j), although all cell types failed to eliminate
mycobacteria. It has been reported before that cMoP show a high
expression of Ms4a313. Thus we examined Ms4a3 expression

levels in the progenitor subsets and found cMoP to have the
highest expression. MC from the bone marrow, deﬁned by their
CD11b expression, did not express Ms4a3, whereas iMoP and
MDP showed distinctly lower levels compared to cMoP (Fig. 7f).
To conﬁrm that iMoP can give rise to CD11b positive monocytes
in vivo, we adoptively transferred iMoP, which had been isolated
from bone marrow of β-actin gfp+/− mice, i.v. (Fig. 7g). After 14
h all transferred iMoP still expressed Ly6C. In the blood, almost
all GFP+ cells had upregulated CD11b. In the spleen and bone
marrow, around 70% showed CD11b expression, whereas F4/80
expression was still rather low in all compartments (Figs. 7g and
h). These observations conﬁrmed that iMoP isolated from the
bone marrow could indeed give rise to inﬂammatory monocytes.
Together these data indicate, that iMoP are a bone marrow
precursor subset between cMoP and CD11b-positive monocytes,
which can give rise to circulating monocytes.
Transferred bone marrow precursors migrate to spleen and
liver granulomas in M. bovis BCG infected mice. Next we
addressed whether immature bone marrow cells localize to the
site of mycobacterial infections and become part of the granuloma. Therefore, we made use of an established model, where M.
bovis BCG i.v. infection leads to granuloma formation in liver and
spleen (Fig. 8a). BCG infection resulted in substantial splenomegaly at day 18 and to a lesser extent at day 30 post infection
(Figs. 8a and b), with CD68-positive, BCG containing granulomas
in the spleen (Fig. 8c) and liver. In accordance with our data on
pulmonary M.tb infection, CD11b−, Ly6C+, CD115+ cells
(including cMoP and iMoP and excluding MC) were increased in
spleen and bone marrow. With respect to the kinetics, these cells
were most frequent at day 18, at the peak of infection, but they
stayed high in number until day 30, especially in the bone marrow (Fig. 8d and Supplementary Fig. 6a). In spleen and blood,
Ly6C+ monocytes were transiently increased at day 18 post
infection, but they decreased to steady state levels until day 30.
Interestingly, the monocyte compartment in the bone marrow
was not signiﬁcantly affected in BCG infection, in contrast to the
precursor subsets (Supplementary Fig. 6b). In addition, granulocytes increased during the infection, whereas B-cells slightly
decreased at day 18 post infection referred to all CD45-positive
cells. The proportions of the T-cell subsets were not altered
during the time course of infection (Supplementary Fig. 6c). Next,
we made use of the BCG infection model to further study the role
of precursor cells in Ccr2−/− mice during infection. As outlined
above, the recruitment of monocyte progenitors is CCR2dependent (Fig. 6g). In contrast to the application of the CCR2
antibody MC-21, which depletes all CCR2-expressing cells
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including those in the bone marrow, we found an accumulation
of bone marrow progenitors both in wild-type and CCR2deﬁcient mice at day 18 post infection (Fig. 8e). In line with the
fact that recruitment of monocytes and their progenitors is
reduced in Ccr2−/− mice, we observed only a minimal increase in
CD115+ CD11b− Ly6C+ cells in the spleens of Ccr2−/− as
12

compared to wild-type mice. In BCG infected Ccr2−/− mice,
Ly6Chigh monocytes were reduced by over 80% in the blood
stream and the spleen as compared to wild-type mice. In contrast,
bone marrow Ly6Chigh monocytes were present at similar frequencies in Ccr2−/− and control mice (Fig. 8f and Supplementary
Fig. 6b). In order to explore, whether monocyte progenitors, in
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Fig. 7 iMoP – a precursor cell between cMoP and monocytes. a Volcano plot of Clariom S gene array analysis of cMoP and iMoP. Depicted are −log10
(p-value) on the y-axis versus log2(fold change) on the x-axis. Shown are signiﬁcantly upregulated (red) and downregulated (green) genes in iMoP compared
to cMoP. b Heatmaps of gene expression in cMoP and iMoP from Cx3cr1gfp/+ mice. Depicted are standardized log2 differences of signiﬁcantly up- (red)
or downregulated (blue) genes. The analysis was performed by GO-Terms (GO:0045087 innate immune response, GO:0030154 cell differentiation,
GO:0007155 cell adhesion, GO:0006629 lipid metabolic process, GO:0016477 cell migration, GO:0019221 cytokine-mediated signaling pathway,
GO:0007049 cell cycle). If GO-Terms overlapped, respective genes were only assigned to one group. Affymetrix Clariom S gene array was performed with
two biologically independent samples per group (1 = sample 1; 2 = sample 2). c Compilation of over-represented gene-ontology-processes with respect to the
signiﬁcantly upregulated genes in iMoP compared to cMoP. d qRT-PCR analysis of Itgam (Cd11b), Adgre1 (F4/80), Mpo, Tlr13, Msr1 and Kit oncogene mRNA
relative to Gapdh mRNA in cMoP, iMoP (red) and MC. Bars show mean ± SEM with n = 3 biologically independent samples. *p = 0.0101 (Tlr13), *p = 0.0142
(Mpo), **p = 0.0038 (Tlr13), **p = 0.0098 (Mpo), ***p = 0.0002 (Itgam, Msr1 cMoP – MC), ***p = 0.0004 (Itgam, Msr1 iMoP – MC), ****p < 0.0001
(ordinary one-way ANOVA, Tukey’s MCT). e cMoP and iMoP (red) were cultured in M3434 Methocult medium. Colonies consisting of at least 10 cells were
counted at day 10. Depicted are means ± SEM of n = 4 biologically independent samples examined over two experiments. f qRT-PCR analysis of Ms4a3 mRNA
relative to Gapdh in MDP, cMoP, iMoP and MC. Bars show mean ± SEM of n = 4 biologically independent samples examined over at least two experiments.
g iMoP isolated from β-actin-gfp+/− mice were transferred intravenously into WT mice. Blood, spleen and bone marrow were analyzed for GFP+ cells (green)
14 h post transfer by FACS for Ly6C, CD11b and F4/80 expression. Representative FACS plots are shown. h Quantiﬁcation of FACS analysis described in
Fig. 7g. Bars show mean ± SEM of n = 5 (blood) and n = 4 (bone marrow, spleen) mice examined over at least three experiments.

particular iMoP, have the potential to localize to the nascent
granuloma, we performed adoptive transfer of monocyte progenitors (CD115+ CD11b−) sorted from the bone marrow of βactin gfp+/− mice at day 20 after infection (Fig. 8g). Again, we
could identify the transferred precursors as GFP+ cells at day 7
post transfer (Fig. 8h). We found that 70–80% of the transferred
cells expressed CD11b after 7 days in spleen and liver. F4/80
expression was slightly higher in the spleen with around 60% than
in the liver with around 40% (Figs. 8h and i). Finally, we quantiﬁed the GFP+, and therefore transferred cells, in immunoﬂuorescence stainings surrounding CD68-positive granulomas
(Fig. 9a and Supplementary Fig. 6d). Around 70% of the transferred precursors were in close contact or part of BCG-containing
granulomas in the liver, whereas in the spleen the distribution
was more variable with around 40% of the cells being associated
to granulomas (Fig. 9b). We performed a 3D reconstruction of a
granuloma and the GFP+ cells to further visualize their relation
and the individual morphology of the transferred cells (Fig. 9c).
We could hereby show that immature bone marrow cells can
quickly transform and differentiate in vivo and integrate into
mycobacterial granulomas.
Transferred bone marrow precursors contribute to MGC formation in M.tb infected IL-13tg mice. In order to further substantiate the MGC-forming potential of monocyte progenitors,
we studied the fate of isolated progenitors in the lung of M.tb
infected mice. Accordingly, we infected IL-13 over-expressing
(IL-13tg) mice with a low dose of 65 CFU M.tb via the aerosol
route. In contrast to other mouse models, including C57BL/6 and
129S2 wild-type mice, IL-13tg mice develop granulomas with
histological structures similar to those found in tuberculosis
patients, including central necrosis and multinucleated giant
cells39. To evaluate whether bone marrow progenitor cells
develop into MGC under inﬂammatory conditions during
experimental tuberculosis, we performed an intratracheal adoptive transfer of CD115+ CD11b− Ly6C+ bone marrow cells,
including cMoP and iMoP, from β-actin gfp+/− mice 6 weeks
after M.tb aerosol infection of IL-13tg mice (Fig. 9d). β-actin
gfp+/− mice were on a C57BL/6 background and did not exhibit
increased expression of IL-13. Three weeks after cell transfer, i.e.,
9 weeks after infection, IL-13tg mice were sacriﬁced and lungs
were analyzed by histology. In addition to GFP, we analyzed
transferred cells for iNOS expression, which is a characteristic
cell-intrinsic marker during MGC development10. Analysis of
tissue slides revealed individual GFP+ cells expressing iNOS
(Figs. 9e1 and 9e2). Moreover, the GFP+ transferred progenitors
contributed to iNOS-positive cell conglomerates resembling

granulomas (Fig. 9e1). In addition, we identiﬁed transferred cells
with atypical nuclear structures, including very large nuclei
(Fig. 9e3) and GFP+ cells with 3 nuclei (Figs. 9e4 and 9e5) in line
with our deﬁnition of MGC. Thus, individual bone marrow
progenitors have the potential to acquire signature MGC properties in M.tb infection in vivo.
Discussion
Adaptation of the host to its microbiota requires tight local
immune control, which balances containment of microorganisms and avoidance of collateral tissue damage with subsequent
organ failure. In other words, a very targeted, yet overall
restrained host response is the basis for efﬁcient commensalism
and thus ultimately for the beneﬁt of the microorganism. It is an
intriguing hypothesis that MGC are involved in mycobacterial
latency, a particular form of host pathogen coexistence. They are
reduced or missing in situations of mycobacterial dissemination,
such as primary immunodeﬁciency syndromes or anti-TNFα
treatment10,40,41. Yet, the speciﬁc contribution of MGC to
mycobacterial immunity is still uncertain42. MGC may inhibit
mycobacterial cell-to-cell spread43, but may just as well
promote tissue destruction due to their high expression of
extracellular matrix-degrading enzymes9. The ﬁndings presented
here suggest that the single-cell adaptation to becoming an MGC
requires progenitor traits, especially proliferative activity, and
commitment to the monocyte lineage. However, the progression
from a dedicated monocyte progenitor to the fully differentiated
MGC involves stepwise cellular reprogramming in a fashion
distinct from that leading to the formation of mature
mononuclear MΦ.
Diverse, and in part controversial, evidence for the role of
differentiated monocytes in mycobacterial pathogenesis has been
previously provided. In humans with active tuberculosis monocytes exhibit a regulatory program that predisposes them to differentiation into alternatively activated MΦ, which are relatively
permissive for mycobacteria44. Ccr2−/− mice, which are deﬁcient
in circulating monocytes, develop smaller lung granulomas and
release less abundant IFNγ into the draining lymph nodes after
embolization with beads coupled to M. bovis components45. This
may be due to impaired trafﬁcking of antigen-presenting cells46,
since monocytes acquire DC characteristics while delivering M.tb
to lymph nodes47. Moreover, type I IFN leads to a CCR2dependent accumulation of permissive lung MΦ and neutrophils
in mice, which promotes tuberculosis exacerbation35,48. These
data are generally in line with our ﬁnding that CCR2-expressing
monocyte progenitors contribute to the formation of the granuloma characteristic MGC in mycobacterial infection. Yet, CCR2
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expression appeared to not be an absolute prerequisite for MGC
formation, both in vitro and in vivo. It is tempting to speculate
that interference of monocyte egress from the bone marrow in
chronic infection triggers complex compensatory programs at the
very heterogeneous host microbe-interface in the tissue.
Previously, it was described that monocytes and MΦ can be
renewed independently of DCs from a committed clonogenic
progenitor present in the bone marrow and spleen denominated
cMoP15. cMoP can be found, albeit in much lower frequency than
in the bone marrow, in the spleen, as an important site of
14

extramedullary hematopoiesis in mice49. In the spleen, cMoPderived monocytes have the ability to differentiate into spleenresident MΦ after depletion of MΦ or upon inﬂammation15. In
addition, the precursor reservoir in the spleen was not empty
during BCG infection of Ccr2−/− mice. This may be due to the
reduced, but not abolished, progenitor recruitment in CCR2deﬁcient mice. On the other hand, it may point towards a
bone marrow independent reservoir in the spleen as an alternative source of progenitor cells in Ccr2−/− mice to cope with the
infection.
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Fig. 8 Increased progenitor frequency in spleen and bone marrow after intravenous BCG infection. a, b C57BL/6 mice were infected with 1–5 × 107 CFU
M. bovis BCG-RFP intravenously (scheme) and analyzed for splenomegaly at day 18 and 30 post infection (p.i.) compared to PBS controls. Representative
images shown (a); quantiﬁcation of spleen size and weight (b). Graphs show mean ± SEM of n = 11 (control), n = 9 (D18) and n = 10 (D30) mice examined
over eight experiments. ***p = 0.0002, ****p < 0.0001 (one-way ANOVA, Tukey’s MCT). c Immunoﬂuorescence staining for CD68 (white) and Hoechst
33342 (blue) of spleens after BCG infection (red) as described in Fig. 8a. Scale bar: 20 µm. Channels were adjusted individually with respect to contrast
and brightness. d FACS analysis from BCG-RFP infected and control mice (as described in Fig. 8a) for frequency of Ly6C+ CD115+ CD11b− cells in spleen
and bone marrow (BM) at day 18 and 30 p.i. Graphs show mean ± SEM of n = 11 (control), n = 9 (D18) and n = 10 (D30) mice examined over eight
experiments. **p = 0.0013 (control – D18, spleen), **p = 0.0086 (D18 – D30, spleen), **p = 0.0053 (BM), ****p < 0.0001 (one-way ANOVA, Tukey’s
MCT). e, f FACS analysis from BCG-RFP infected C57BL/6 (WT) and Ccr2−/− mice (blue) for frequency of Ly6C+ CD115+ CD11b− cells (e) and Ly6Chigh
monocytes (f) in spleen, BM and blood at day 18 p.i. compared to PBS controls (C57BL/6) in the described infection model (Fig. 8a). Graphs show mean ±
SEM of n = 6 (control, WT) and n = 5 (Ccr2−/−) mice examined over two experiments (one experiment removed due to high variance in initial infection
dose). *p = 0.017 (control − WT BCG), *p = 0.0449 (control − Ccr2−/− BCG), ***p = 0.0002 (e), ***p = 0.0001 (f, spleen), ***p = 0.0004 (f, blood),
****p < 0.0001 (one-way ANOVA, Tukey’s MCT). g Scheme of adoptive transfer model. CD11b− CD115+ cells from β-actin-gfp+/− mice were transferred
into BCG-RFP (1–5 × 107 CFU i.v.) infected WT mice 3 weeks p.i. FACS and microscopical analysis followed at day 7 post transfer. h, i FACS analysis and
quantiﬁcation of CD11b, Ly6C and F4/80 expression of GFP+ cells (green) in spleen and liver after adoptive transfer (Fig. 8g). Depicted are mean ± SEM of
n = 4 recipient mice examined over three experiments.

Importantly, a human cMoP analogue has been recently
identiﬁed as a CLEC12AhighCD64high subset in umbilical cord
blood and in bone marrow. Using established gating strategies,
this subset is included in the conventional GMP fraction16.
Accordingly, cMoP have become established as the most speciﬁc
monocyte progenitor in bone marrow and spleen. Under
homeostatic conditions, cMoP differentiate into Ly6Chigh
monocytes in the bone marrow, egress and, in part, give rise to
Ly6Clow monocytes and MΦ50. However, it had not previously
been clariﬁed how monocyte and MΦ transformation is achieved
under conditions, when these cells are most needed for immune
defense, i.e., when microorganisms infect the tissue. Here, we
introduce a circulating MΦ progenitor, which, according to our
in vitro and in vivo differentiation analysis, is interposed between
cMoP and inﬂammatory monocytes. This cell type, which we
denominate iMoP, is best characterized by the loss of CD117.
iMoP remain negative for the myeloid lineage marker CD11b, but
are positive for CD115, which is why we attribute them as a
monocyte/MΦ progenitor. Chong et al. established a new classiﬁcation of mature bone marrow monocytes with respect to
expression of CXCR451. As the CXCR4+ Ly6C+ cells, they
described, are partly CD11b−, our iMoP subset might be a further
subpopulation of the CXCR4+ bone marrow subset. In vitro, the
iMoP phenotype is, similar to the cMoP phenotype, very transient
and lasts only a few hours. In accordance with this, iMoP differentiated in vivo within 14 h into CD11b+ Ly6C+ monocytes.
The speciﬁc dedication of cMoP to its progenitor trait was based
in part on strongly reduced Ccr2 mRNA expression compared to
monocytes of the bone marrow15, which was in line with the
notion that cMoP hardly egress from the bone marrow, and on
their inability to take up particles as an essential functional
phagocyte feature15. Here, we substantially extend the cellular
potential of cMoP and its descendants. First, we found cMoP to
express CCR2 on the protein level, and their number to be
reduced in the bone marrow of CCR2-mAb treated mice. This
indicates their potential to circulate and home to target tissues
under certain conditions. Yet, this may occur at a very low frequency and thus evade conventional analysis. Second, we found
that cMoP exhibit sensors and effector molecules involved in
mycobacterial immunity. They express TLR2, a cognate receptor
for mycobacterial glycolipids and lipoproteins and produce
abundant TNFα in response to TLR2 ligation. In addition, a
unique regulation of lipid metabolism in cMoP appears to bridge
progenitor and immune cell functions. Conversion of MΦ into
MGC is associated with foamy cellular transformation, as indicated by the accumulation of cholesterol and lipids in the cytosol.
Our data strongly suggest that reprogramming of fatty acid and

cholesterol metabolism and efﬂux are critical prerequisites for
MGC formation. The metabolic MGC imprint likely involves
high availability of free fatty acids, either through de novo fatty
acid synthesis or degradation of triacylglycerols, since both are
inhibited by the general lipase inhibitor tetrahydrolipstatin
(orlistat). Moreover, and probably more important in the context
of our study, orlistat tightly binds and irreversibly inhibits the
fatty acid synthase28 and triacylglycerols degradation29. However,
the cellular processes leading to the accumulation of lipids and
the transformation into a foamy cell remain highly cell speciﬁc.
As an example, whereas orlistat has potent activity against the
accumulation of fatty acids in MGC, it increases lipid droplets in
hepatic stellate cells in number and size. Under these conditions,
orlistat inhibits the breakdown of cholesterol esters29. Accumulation of fatty acids is a clear indication for changes in the lipid
handling by MGC, yet the biological role of this phenomenon is
less clear. The accumulation of cholesterol and lipids in MGC
may represent an enlarged reservoir, since less membrane material is needed in one slowly enlarging cell as compared to macrophages undergoing cellular ﬁssion and daughter cell formation.
The inhibition of MGC formation by orlistat highlights the role of
fatty acid de novo synthesis and metabolism for cellular energy
production. In addition, M.tb uses host lipids to produce energy
largely through β-oxidation, to generate biosynthetic progenitors
needed for pathogenesis and to incorporate them into membrane
phospholipids to maintain cytoplasmic membrane integrity52.
Overall, host cholesterol appears to be required for proper growth
and persistence of M.tb in vivo53–55. In addition, a high cholesterol content in the cell membrane supports the uptake of
mycobacteria56. In line with this, interfering with cholesterol
synthesis has been shown to reduce mycobacterial numbers both
in MΦ in vitro and in experimental mouse models57,58 and has
been used as an adjunct therapy in patients with tuberculosis59.
Furthermore, cholesterol import is a prerequisite for mycobacterial persistence in the lungs of chronically infected animals,
where mycobacteria localize to MΦ60. It is well appreciated that
M.tb infection induces a foamy phenotype in mononuclear MΦ,
which may provide a permissive growth environment for the
bacteria. Our data on increased mycobacterial loads in monocyte
progenitor as compared to MC is in line with this notion,
although in vitro killing assays have to be taken with some caution, given the complexity of a mixed bacterial-host cell culture
(e.g., competitive metabolism, cell death etc.). Moreover, our data
clearly indicate that the dependence on cholesterol for MGC
transformation is independent of mycobacterial metabolism,
since MBCD inhibited MGC in response to both pure TLR2
ligands and metabolically inactive mycobacteria. With regard to
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the ﬁndings of Tornack et al.61 who detected M.tb DNA in peripheral blood and hematopoietic stem cells of humans during
latent Tb infection, the accumulation of lipids in progenitor cells
might also provide a suitable environment for mycobacteria.
Moreover, it is conceivable that monocyte progenitors may serve
as Trojan horses for mycobacteria contributing to Tb reactivation.
Spann et al. reported a link between the process of foam cell
transformation and inﬂammatory response via accumulation of
desmosterol31. Our sterol analysis of cMoP-derived MGC also
16

revealed an accumulation of the cholesterol precursor desmosterol. Nonetheless, TLR2-induced cMoP-derived MGC differ in
the expression of e.g., Dhcr24 and Abca1 from the atherosclerosisassociated foam cells Spann et al.31 described, indicating further
regulatory mechanisms to play a role during the transformation
process into a MGC.
The role of MGC has been a matter of considerable debate. The
most accepted hypothesis, which incorporates ﬁndings in osteoclasts, states that MGC are superior to mononuclear phagocytes
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Fig. 9 Transformation of bone marrow precursors in BCG infected wild-type mice and M.tb infected IL-13tg mice. a Representative immunoﬂuorescence
staining of CD68-positive liver granulomas (yellow dotted line) surrounded by GFP+ cells (green) after adoptive transfer as described in Fig. 8g.
CD68 staining is shown in white, Hoechst staining in blue and BCG-RFP in red. (1) shows an enlarged section of a granuloma. Scale bar: 20 µm. Channels
were adjusted individually with respect to contrast and brightness. b Quantiﬁcation of granuloma-associated transferred cells in immunoﬂuorescence
stainings of spleen and liver after adoptive transfer as described in Fig. 8g. Depicted are mean ± SEM of n = 5 mice examined over four experiments. c 3D
reconstruction of a CD68-positive (white) granuloma (scale bar: 10 µm) and detailed close-ups (1 and 2, scale bar: 5 µm) of GFP+ cells (green) performed
from immunoﬂuorescence staining described in Fig. 9a. BCG-RFP is shown in red and nuclei are depicted in blue. d Scheme of adoptive transfer model.
CD11b− CD115+ Ly6C+ cells isolated from β-actin-gfp+/− mice were intratracheally transferred into n = 3 M.tb infected IL-13tg mice 6 weeks post infection.
Mice were infected via aerosol with M.tb (H37Rv, 65 CFU). Microscopical analysis followed 3 weeks post transfer. e Individual GFP+ cells from the model
described in Fig. 9d are shown. Nuclear stain (Hoechst 33342) is depicted in blue, iNOS staining in red and transferred GFP+ cells in green (scale bars: 10
µm). Adoptive transfer and staining were performed for n = 3 recipient mice. 2 and 4 depict maximum intensity projections of several Z-stacks. Channels
were adjusted individually with respect to contrast and brightness. The orange dotted lines represent the cell boundaries, the white dotted lines or white
arrows mark the nuclei.

in the uptake and degradation of large particles due to their size
and increased functional properties of the endosomes62,63.
However, this hypothesis has been disputed recently since MGC
have been found to be a less hostile environment to mycobacteria
than other macrophage-like cells and rather allow for cellular
persistence10,64,65. Our ﬁnding that dedicated monocyte progenitors are programmed by the infecting mycobacteria to progress towards cell subsets facilitating replication and persistence
extends existing models of host-mycobacteria adaptation.
Mycobacteria piggy-back the evolutionarily conserved antibacterial nitric oxide response to create a permissive cellular
environment. At the same time, MGC locally contain the infection rather than allowing bacterial spread. MGC are relatively
immobile and exhibit heightened phagocytic properties, which
allow them to engulf apoptotic infected cells in the immediate
vicinity. Thus, mycobacteria-driven genesis of MGC encompasses
reprogramming of dedicated monocyte progenitors and represents an intriguing example of host-microbe coevolution offering
mutual beneﬁts. The hypothesis that mycobacteria have the
potential to reprogram progenitor cells is supported by the
observations that BCG and M.tb differentially impact on the
transcriptional program in stem cells in vivo66,67. Adoptive
transfer of CD115+ CD11b− immature bone marrow cells yielded that these cells can migrate to M. bovis BCG-induced liver
granulomas and acquire the morphology of granuloma-associated
macrophages. As most Tb mouse models do not show typical
granuloma formation in M.tb infection, we further analyzed the
role of progenitor cells in M.tb infected IL-13tg mice which are
capable of forming MGC39. After intratracheal transfer of
CD115+ Ly6C+ CD11b− bone marrow cells, we observed cells
with 3 nuclei and iNOS expression as markers for MGC
formation10. At this stage the contribution of a T helper 2
inﬂammatory environment remains to be established.
In summary, we herewith introduce both cMoP and their
circulating progeny iMoP as myeloid cell hybrids, which comprise
both progenitor potential and immune cell functions in mycobacterial infections. The identiﬁcation and characterization of
dedicated, and potentially circulating MGC progenitors, opens
perspectives in deﬁning, and eventually modulating, the role of
MGC in mycobacterial granulomas and beyond.
Methods
Mice. All knock-out mice were on C57BL/6 genetic background and used at 6 to
10 weeks of age. Female and male mice were included in the experiments. C57BL/
6J and C57BL/6N mice were purchased from Jackson Laboratories (USA) or
Charles River Laboratories (Germany). Cx3cr1gfp/+ mice were obtained as a kind
gift from Steffen Jung (Weizmann Institute, Israel). iNOS-deﬁcient mice
(Nos2tm1Lau) and β-actin gfp+/− (C57BL/6-Tg(CAG-EGFP)131Osb/LeySopJ) were
purchased from Jackson Laboratories (USA). Andreas Diefenbach (Institute of
Microbiology, Infectious Diseases, and Immunology, Berlin) provided Ccr2−/−
mice for infection with M. bovis BCG as a kind gift. Mice were bred in animal

facilities of the University of Freiburg under speciﬁc pathogen-free conditions.
Mice were kept in groups of maximum of ﬁve animals at a room temperature of
21 °C (±0.5–1 °C) and a humidity of 55% (±5–8%). Food and water were available
ad libitum, and day/night cycles were set to 12 h. Animal experiments under
Biosafety level 2 were approved by the Regierungspräsidium Freiburg (G-19/171).
For M.tb infections, 129S2 and C57BL/6J mice, originally bought from Charles
River Laboratories (Germany), were bred at the Max-Planck-Institute for Infection
Biology in Berlin. Mice between 9 and 12 weeks old were infected and maintained
under Biosafety level 3. Animal experiments were approved by the State Ofﬁce for
Health and Social Services (Landesamt für Gesundheit und Soziales), Berlin,
Germany (G040393/12). IL-13-over-expressing (tg) mice68 were on a C57BL/6
genetic background and bred under speciﬁc pathogen-free conditions at the
Research Centre Borstel. Infections of IL-13tg mice with M.tb were performed
under Biosafety level 3 and approved by the Animal Research Ethics Board of the
Ministry of Energy, Agriculture, the Environment, Nature and Digitalization
Schleswig-Holstein, Kiel, Germany (approval number 3-1/19). CCR2-deﬁcient
mice for M.tb infection were purchased from Jackson Laboratories (USA) and bred
at the animal facility at Washington University in St. Louis. The M.tb infection
experiments of Ccr2−/− mice were in accordance with the Washington University
in St. Louis Institutional Animal Care and Use Committee guidelines.
Mycobacterium bovis BCG. M. bovis BCG-medac/Vejicur (Bacillus CalmetteGuérin) and with pSMT3-dsRed+hygromycin (Prof Zakaria Hmama, Vancouver)
transformed BCG-RFP were grown to log-phase in Difco Middlebrook 7H9 broth
(Becton Dickinson, BD), supplemented with 10% Middlebrook OADC Enrichment
(Becton Dickinson, BD) and 0.5% Glycerol, with the addition of 50 µg/ml
Hygromycin B (Streptomyces sp., 400052, Merck Millipore) for BCG-RFP. BCG was
heat-ﬁxed by incubating for 30 min at 80 °C on a shaker.
M.tb infection of C57BL/6 and 129S2 mice and tissue processing for cell
analysis. Female C57BL/6 and 129S2 mice were co-housed one week prior to
experiments. Mice were infected with low dose Mycobacterium tuberculosis (strain
H37Rv, 200 CFU), using the Glas-Col inhalation exposure system. 24 h after
infection, the amount of inhaled bacteria was controlled in ﬁve mice by plating the
whole lung and counting CFU after 21 days of incubation at 37 °C. 7, 14, and
21 days after infection, blood and bone marrow from mice were analyzed by ﬂow
cytometry for progenitor frequency. Brieﬂy, mice were lethally anesthetized with
Ketamin/Xylazin i.p. and blood was readily collected from the inferior vena cava in
syringes containing anti-coagulant (EDTA). Bone marrow was collected by
ﬂushing femoral bones with RPMI1640 media. Cells were resuspended in FACS
buffer (1% FBS, 2 mM EDTA), blocked for unspeciﬁc binding with rat-IgG and
anti-FcR antibodies and stained in the dark for 30 min at 4 °C. Details on antibodies used are presented in the section: Surface and intracellular staining. Finally,
samples were ﬁxed in 4% PFA for 30 min at room temperature (RT). Staining of
blood cells was performed in whole blood. Following blocking and antibody
incubation, it was transferred into ﬁx/lyse solution (eBioscience) for 30 min at RT.
Cells were acquired on the CytoFLEX S (Beckman Coulter) ﬂow cytometer and
analyzed with the FlowJo software (Treestar).
CCR2-antibody injection in vivo. For analysis of CCR2-dependent recruitment of
iMoP, 129S2 mice were infected with a low dose of M.tb (H37Rv) as indicated.
Starting on day 14 post infection (p.i.), mice were intraperitoneally (i.p.) injected
with 20 µg of a CCR2 speciﬁc antibody (MC-21) or an isotype control (MC-67)
daily. On day 14 and 19 p.i., ﬁve mice per group were euthanized and lungs and
spleen plated for CFU assessment. Cells from blood and bone marrow were analyzed for frequency of cMoP and iMoP at day 19.
M. bovis BCG infection model. C57BL/6 or Ccr2−/− mice were infected with
~1–5 × 107 CFU M. bovis BCG intravenously. Eighteen and thirty days after
infection mice were sacriﬁced and spleen size and weight were measured. Spleen,
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blood, and bone marrow were analyzed by ﬂow cytometry for frequency of progenitors and other immune cells. Spleens were analyzed for granuloma formation
by confocal microscopy. Brieﬂy, mice were lethally anesthetized and blood was
collected from the retroorbital plexus with capillaries containing anti-coagulant
(EDTA), followed by a RBC lysis (eBioscience™ 1X RBC Lysis Buffer). Bone
marrow was collected by ﬂushing femoral bones with FACS buffer (1% FBS, 2 mM
EDTA). Spleens were smashed through a 70 µm strainer and RBC lysis
(eBioscience™ 1X RBC Lysis Buffer) was performed. After washing cells were
resuspended in FACS buffer (1% FBS, 2 mM EDTA), blocked for unspeciﬁc
binding with anti-FcR antibody and stained in the dark for 30 min at 4 °C. Details
on antibodies used are presented in the section: Surface and intracellular staining.
Cells were analyzed at a 3-laser ﬂow cytometer (Gallios™, Beckman Coulter) and
processed with the Kaluza software (v1.5, Beckman Coulter).
Adoptive transfer model of M. bovis BCG infected mice. C57BL/6 mice were
infected with 1–5 × 107 CFU M. bovis BCG intravenously. At day 20 post infection
CD115+ CD11b− GFP+ bone marrow cells were intravenously injected. These cells
were isolated from β-actin gfp+/− mice, continuously expressing GFP on their bone
marrow cells except from erythrocytes. The Dynabeads™ (Thermo Fisher Scientiﬁc)
puriﬁcation of bone marrow cells for cell sort is described in the section: Isolation
of bone marrow progenitor cells. The remaining bone marrow cells were stained
with CD11b APC eFluor 780 (eBioscience) and CD115 REAlease® PE antibody
(Miltenyi Biotec). After cell sort of CD115+ CD11b− GFP+ cells, bound CD115
REAlease® antibody was removed with a REAlease® kit (Miltenyi Biotec) following
the manufacturer´s instructions. Cells were resuspended in PBS + 2% murine
serum. Murine serum was obtained from donor mice and sterile ﬁltered. Afterwards cells were injected intravenously into infected WT recipient mice
(~0.6–1.2 × 106/animal). Control mice received PBS + 2% murine serum alone.
Recipients were analyzed 7 days post transfer for surface marker (CD11b, Ly6C,
F4/80) expression on GFP+ transferred cells in blood, spleen, bone marrow, and
liver by ﬂow cytometry. Blood, spleen, and bone marrow were collected and prepared as described in the section: M. bovis BCG infection model. The liver was
smashed through a 100 µm strainer, followed by a RBC lysis (eBioscience™ 1X RBC
Lysis Buffer). After washing cells were resuspended in FACS buffer (1% FBS, 2 mM
EDTA), blocked for unspeciﬁc binding with anti-FcR antibody and stained in the
dark for 30 min at 4 °C for CD11b, Ly6C, F4/80. Details on antibodies used are
presented in the section: Surface and intracellular staining. Cells were analyzed at a
3-laser ﬂow cytometer (Gallios™, Beckman Coulter) and processed with the Kaluza
software (v1.5, Beckman Coulter).
Confocal microscopy of spleen and liver sections. Spleen and liver of infected
and transferred mice were partly ﬁxed in 4% paraformaldehyde for 4 h and then
put into 20% sucrose till organs sank to the bottom of the tube. Afterwards organs
were embedded in Tissue-Tek® O.C.T™ Compound (Sakura) and shock frozen in
liquid nitrogen. Slices of 8-µm thickness were cut at a crytome and washed using
washing buffer (0.1% Triton-X100, 1% BSA in 1× PBS). Cryotome sections were
kept in washing buffer for 5 h at 4 °C in the dark. After removing washing buffer,
slices were stained with CD68 AF647 (BioLegend), anti-GFP DyLight 488 (Rockland Immunochemicals), and Hoechst 33342 and incubated overnight at 4 °C in
the dark. Samples were washed three times in washing buffer and mounted with
ProLong™ Diamond Antifade Mountant (invitrogen). Before acquiring samples at
the microscope, slices were kept for 24 h at 4 °C in the dark for drying. Confocal
microscopy was performed on three slices of spleen and liver per animal. Between
each slice at least 120 µm were discarded to analyze different parts of the organs.
Pictures were taken on a LSM 710 and LSM 880 with a ×20 objective (numerical
aperture 0.8) and analysis followed with ZEN 2012. In order to image whole organ
sections of spleen and liver tile scans were performed with an overlay of 10%
(Figs. 8c, 9a and Supplementary Fig. 6d). Brightness, contrast, and gamma correction were adjusted for ideal evaluation conditions. The picture for the 3D
analysis of a granuloma was taken with a ×63 objective (numerical aperture 1.4)
and analysis was performed with Imaris x64 9.5.0.
Adoptive transfer of iMoP. iMoP were isolated from β-actin gfp+/− mice, continuously expressing GFP on their bone marrow cells except for erythrocytes. The
Dynabeads™ (Thermo Fisher Scientiﬁc) puriﬁcation of bone marrow cells for cell
sort is described in the section: Isolation of bone marrow progenitor cells. The
remaining bone marrow cells were stained for CD11b, CD115, Ly6C, and CD117.
After cell sort of CD117− Ly6C+ CD115+ CD11b− GFP+ cells (iMoP), cells were
resuspended in PBS + 2% murine serum. Murine serum was obtained from donor
mice and sterile ﬁltered. Afterwards cells were injected intravenously into WT
recipient mice (~1–3 × 105/animal). Control mice received PBS + 2% murine
serum alone. Recipients were analyzed 14 h post transfer for surface marker
expression on GFP+ transferred cells in blood, spleen, and bone marrow by ﬂow
cytometry. Blood, spleen, and bone marrow were collected and prepared as
described in the section: M. bovis BCG infection model. After washing cells were
resuspended in FACS buffer (1% FBS, 2 mM EDTA), blocked for unspeciﬁc
binding with anti-FcR antibody, and stained in the dark for 30 min at 4 °C for
CD11b, Ly6C, F4/80. Details on antibodies used are presented in the section:
Surface and intracellular staining. Cells were analyzed at a 3-laser ﬂow cytometer
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(Gallios™, Beckman Coulter) and processed with the Kaluza software (v1.5, Beckman Coulter).
M.tb infection of IL-13tg mice and progenitor transfer. IL-13tg mice were
infected with a low dose of 65 CFU M.tb by aerogenic exposure in a Glas-Col
inhalation exposure system. Six weeks post infection, enriched CD115+ CD11b−
Ly6C+ GFP+ bone marrow cells from β-actin gfp+/− mice were transferred
intratracheally. Puriﬁcation of bone marrow cells by magnetic bead-based cell
enrichment prior to ﬂuorescence-activated cell sorting (FACS) is described in the
section: Isolation of bone marrow progenitor cells. Enriched bone marrow cells
were stained with CD11b APC eFluor 780 (eBioscience), CD115 BV 421 (BioLegend) and Ly6C PerCP-Cy5.5 (BioLegend). FACS was performed on a FACS Aria
Illu (BD Bioscience). 2–4 × 105 CD115+ CD11b− Ly6C+ GFP+ progenitor cells
were transferred per infected IL-13tg mouse. Intratracheal cell transfer was
achieved by aspiration of the resuspended progenitors. In short, mice were
anaesthesized with isoﬂurane, progenitor cells resuspended in 30 µl PBS and
installed in the oropharynx of the infected mice. Control mice only aspirated PBS.
Recipients were analyzed 3 weeks post transfer. Lungs were parafﬁn-embedded for
histology and microscopic slices of 6-µm thickness cut on a microtome. After airdrying slides were deparafﬁnized and antigen-retrieval performed in citrate buffer
(10 mM citric acid, 0.05% Tween 20, pH 6.0) for 20 min at 90 °C. Blocking and
immunoﬂuorescence staining for NOS2 (Thermo Fisher Scientiﬁc), anti-GFP
DyLight 488 (Rockland Immunochemicals), and Hoechst 33342 were performed
similar to the description in the section: Confocal microscopy of spleen and liver
sections. Confocal microscopy was performed on a LSM 880 with a ×40 objective
(numerical aperture 1.2) and analysis followed with ZEN 2012. Brightness and
contrast were adjusted for ideal evaluation conditions.
Histopathological analysis of M.tb infected CCR2-deﬁcient mice. Ccr2−/− and
C57BL/6 control mice were infected with a low dose (100 CFU) of M.tb (hypervirulent strain HN878) in a Glas-Col inhalation exposure system. Lungs were
harvested 60, 100, and 300 days post infection and parafﬁn-embedded. Parafﬁn
sections were deparafﬁnized followed by an H&E staining. In short, Haematoxylin
(GIL III) was added for 4 min. Slides were washed in tap water for 5 min, rinsed
with 0.1% HCl and again washed in tap water. Eosin 1% was added for 1 min,
followed by washing in tap water. After dehydration slides were mounted in
ROTI®Histokitt (Carl Roth). Slides were scanned with a ZEISS Axio Scan.Z1 with a
×20 objective, followed by a histopathological analysis with respect to area of
inﬂammation, foam and giant cells, and cellular composition of the
inﬂammatory area.
Cell culture. After isolation, cells were cultured at 37 °C in Opti-MEM® I Reduced
Serum Medium, GlutaMAX™ Supplement with 10% FBS (Gibco, Thermo Fisher
Scientiﬁc) and Ciproﬂoxacin (5 mg/ml, Fresenius) in 48- or 96-well plates (CellBind Surface, Corning). Cells were cultured with 50 ng/ml recombinant murine MCSF from Peprotech. For stimulation, ligands or bacteria were added to the wells.
Lipomannan from M. smegmatis and ﬁxed M. tuberculosis were purchased from
InvivoGen. BCG (MOI 20 or 100) or ﬁxed BCG (106/ml) were used for stimulation.
Surface and intracellular staining. Ter119 Biotin, CD3e Biotin, CD19 Biotin,
SiglecF Biotin, Sca-1 Biotin, CD127 Biotin, CD115 PE, CCR2 APC, CD11b VioGreen anti-mouse antibodies were purchased from Miltenyi Biotec. CD16/32
puriﬁed (Fc-Block), Ly6G Biotin, CD117 Paciﬁc Blue, CD117 BV 421, CD115 BV
421, F4/80 BV421, CD3e APC anti-mouse antibodies and Rat IgG2a Isotype BV421
were bought from BioLegend and CD4 PerCP Cy5.5, CD45 FITC, CD45 eFluor
450, CD45 PerCP Cy5.5, Ly6C PerCP Cy5.5, CD11b APC-eFluor 780, F4/80 PE,
iNOS APC, Streptavidin PeCy7 and Rat IgG2a Isotype PE anti-mouse antibodies
were purchased from eBioscience. Ly6G FITC anti-mouse antibody was from BD
biosciences. F4/80 APC was purchased from Bio-Rad. Cells were stained in FACS
buffer containing 1X Dulbecco’s Phosphate Buffered Saline (Gibco, Thermo Fisher
Scientiﬁc) with 1% FBS and 2 mM EDTA for 30 min at 4 °C.
For CCR2 staining cells were incubated with anti-CCR2-Antibody (MC-21)69,
or isotype control. Samples were then stained with rabbit-anti-rat secondary
antibody conjugated to Alexa Fluor-488 (Thermo Fisher Scientiﬁc).
For intracellular staining, cells were ﬁxed and permeabilized with the Fixation/
Permeabilization Solution Kit (BD Bioscience) according to the manufacturer’s
instructions. Samples were analyzed at a 3-laser ﬂow cytometer (Gallios™, Beckman
Coulter) and processed with the Kaluza software (v1.5, Beckman Coulter). Hoechst,
TNFα and ﬁlipin staining were recorded with a BD LSR Fortessa ﬂow cytometer
(Becton Dickinson). Details on FACS antibodies are provided in Supplementary
Table 1.
Isolation of bone marrow progenitors. Bone marrow cells were isolated from
tibia, femur, and humerus of mice. Tissue was removed from the respective bones,
and bones were ﬂushed with sterile FACS buffer. To obtain a single-cell suspension,
cells were passed through a 70 µm cell strainer. After washing, cells were stained for
20 minutes at 4 °C with biotinylated Ter119, CD3e, CD19, SiglecF, CD127, Sca-1,
Ly6G antibodies in FACS buffer. After washing in PBS containing 1% BSA, labeled
cells were removed using Dynabeads™ (Thermo Fisher Scientiﬁc) according to the
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manufacturer’s instructions. The amount of Dynabeads™ needed was titrated.
Remaining cells were stained for CD115, CD117, CD11b and Ly6C. Progenitor
populations were separated using a MoFlo® Astrios™ cell sorter (Beckman Coulter).
Isolation of blood monocytes. Mice were anaesthetized with Ketamin/Xylazin i.p.
and blood was drawn from the retro-orbital plexus. Erythrocytes were lyzed in RBC
Lysis buffer solution (eBioscience™ 1X RBC Lysis Buffer). The remaining cells were
washed in FACS buffer and stained for CD45, CD11b, CD115, and Ly6C as
described above. Ly6Chigh and Ly6Clow blood monocytes were isolated with a
MoFlo® Astrios™ cell sorter (Beckman Coulter).
Hemacolor staining. Hemacolor® rapid staining for blood smears (Merck Millipore) was used to ﬁx and stain cells. Brieﬂy, cells were ﬁxed in staining solution 1
for 5 seconds (Methanol), followed by staining with solutions 2 and 3 for 5 s each.
Cells were washed twice in Hemacolor buffer and stored in dH2O at 4 °C.
Microscopy of Hemacolor staining was performed with an Axiovert 200 M ApoTome (Zeiss, objective: x20). For processing images, ZEN 2012 (Zeiss) was used.
Cytospin. Progenitor cells were resuspended in 0.5% human serum albumin (HSA) and transferred to microscope slides by centrifugation in a cytospin slide
chamber for 5 min. After air drying, slides were stained by Hemacolor staining as
described above and analyzed with an Axiovert 200 M ApoTome (Zeiss,
objective: ×63).
Cell density. Sorted cMoP were seeded in 96-well plates and stimulated with MCSF (50 ng/ml) and ﬁxed BCG (106/ml) or with M-CSF (50 ng/ml) alone as
control. At day 6 cells were scraped, stained for ﬂow cytometry with CD45 eFluor
450 30 min at 4 °C in the dark. After washing SPHEROTM AccuCount ﬂuorescent
particles (Spherotech) were added and samples were acquired by ﬂow cytometry.
Cell number/ml was calculated according to the manufacturer´s instructions.
Killing assay. cMoP, iMoP, and MC were isolated from WT mice and 4000 cells/
well were plated in a 96-well plate (Corning) with M-CSF (50 ng/ml) as described
above. The cells were incubated for 14 h at 37 °C and then inoculated with M. bovis
BCG RFP (MOI 10) for 6 h. Gentamicin (50 µg/ml, Thermo Fisher) was then added
to eliminate extracellular bacteria. Cells were incubated for four days at 37 °C.
Then, cells were gently washed with PBS. Hundred microliters of lysis buffer
(0.05% SDS in PBS) were added to each well and incubated 5 min at RT. Following
cell lysis, wells were thoroughly scraped. Serial dilutions of the lysates were plated
on Middlebrook 7H11-agar plates and incubated for 10–14 days at 37 °C. Colonies
were counted and the bacterial concentration/ml was calculated. Cells were
counted by ﬂow cytometry with SPHEROTM AccuCount ﬂuorescent particles
(Spherotech) and bacterial concentration was referred to cell concentration
per well.
CFSE staining. 5-(and 6)-Carboxyﬂuorescein diacetate succinimidyl ester (CFSE)
was purchased from eBioscience (eBioscience™ CFSE, Thermo Fisher). Bone
marrow progenitors were stained in a 5 µmol CFSE staining solution immediately
after cell sorting for 5 min at 37 °C. Subsequently, cells were washed in cold FACS
buffer and resuspended in full Opti-MEM medium and cultured with respective
stimulants plus M-CSF, or M-CSF alone (control). At the indicated time points,
cells were harvested by scraping, stained for CD45 and analyzed by ﬂow cytometry.
To standardize the ﬂow cytometer settings between the different time points and
replicates, Flow-Set Pro Fluorophere Flow Cytometer standardization reagent
(Beckman Coulter) was used. Data were analyzed by ModFit LT™ Software (Verity
Software House) and FlowJo analysis software (Version 10). The ﬁrst CFSE
expression peak at 5 h was used
(i = 1). Proliferation index
 as undivided
generation

(PI) was determined as PI ¼

i

∑ i  N2ii
1

i

∑ N2ii , with i = generation number
1

and N = number of cells in generation i, indicating the average number of divisions
responding cells have undergone70. N and i were deﬁned with ModFit LT™
Software.
Apoptosis assay. cMoP and MC from WT mice were cultured as described above.
As a positive control for apoptosis, progenitors cultured in M-CSF were stimulated
with staurosporine from Streptomyces sp. (1 µg/ml, Sigma Aldrich) for 5 h at 37 °C
at day 6. Samples were harvested by scraping and transferred to FACS tubes
together with the supernatant. After washing, cells were resuspended in 200 µl PBS
and 2 ml Ethanol was added slowly during vortexing. After ﬁxation for 30 min on
ice, cells were washed twice and stained for 30 min in DNA staining solution (20
µg/ml propidium iodide, BioLegend, and 200 µg/ml RNAse A, Thermo Fisher,
Scientiﬁc, in PBS). Samples were analyzed directly by ﬂow cytometry and the
percentage of cells in subG1 phase represented the apoptotic cells71.
MitoSpy™ NIR DilC1(5) assay. cMoP and MC from WT mice were cultured as
described above. As a positive control for apoptosis, progenitors cultured in M-CSF
were stimulated with staurosporine from Streptomyces sp. (1 µg/ml, Sigma Aldrich)
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for 5 h at 37 °C at day 6. Samples were harvested by scraping and transferred to
FACS tubes together with the supernatant. Samples were stained with 50 nM
MitoSpy™ NIR DilC1(5) (BioLegend) and CD45 FITC antibody for 15 min at 37 °C.
After washing cells were resuspended in FACS buffer, DAPI was shortly added
before analysis by ﬂow cytometry for dead cell exclusion. Gate for apoptotic cells,
so cells with a low ΔΨm (mitochondrial potential), was deﬁned with the staurosporine positive control.
TNFα assay. After isolation, bone marrow progenitors from Cx3cr1gfp/+ mice were
cultured for 5 h as described above with appropriate stimulants and together with
GolgiStopTM (BD, Germany). After scraping and washing, cells were ﬁxed by the
Fixation/Permeabilization Solution Kit (BD Bioscience) according to the manufacturer’s instructions. For intracellular staining, TNFα-APC-antibody from BD
Pharmigen was added and staining performed at room temperature for 20 min.
After washing, samples were analyzed at a BD LSR Fortessa ﬂow cytometer (Becton
Dickinson). Unstimulated cells served as control.
Microarray. Sample preparation for microarray hybridization was carried out as
described in the Affymetrix GeneChip WT Pico Reagent Kit User Guide (Affymetrix, Inc., Santa Clara, CA, USA).
1. Affymetrix Mouse Gene 2.1 ST (compare Fig. 3 and Supplementary Fig. 2)
In brief, 5 ng of total RNA was used for reverse transcription to synthesize
single-stranded (ss) cDNA with a T7 promoter sequence at the 5′ end. Next
a 3′ adaptor was added and the ss cDNA was converted to double-stranded
cDNA, which acted as a template for a pre- in vitro transcription (IVT)
ampliﬁcation by a low-cycle PCR. Afterwards antisense RNA (complementary RNA or cRNA) was synthesized and linearly ampliﬁed by an in vitro
transcription (IVT) of the double-stranded cDNA template. 20 µg of cRNA
was puriﬁed and reverse transcribed into sense-strand (ss) cDNA, whereat
unnatural dUTP residues were incorporated at a ﬁxed ratio relative to dTTP.
Puriﬁed ss cDNA was fragmented using a combination of uracil DNA
glycosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE 1) at the
dUTP residues followed by terminal labeling with biotin. 3.8 µg of
fragmented and labeled ss cDNA were hybridized to Affymetrix Mouse
Gene 2.1 ST Array Plates. For hybridization, washing, staining, and scanning
an Affymetrix GeneTitan system, controlled by the Affymetrix GeneChip
Command Console software v4.2, was used.
2. Clariom S Array (compare Fig. 7)
In brief, 5 ng of total RNA was used for reverse transcription to synthesize
single-stranded (ss) cDNA with a T7 promoter sequence at the 5′ end. Next
a 3′ adaptor was added and the ss cDNA was converted to double-stranded
cDNA, which acted as a template for a pre- in vitro transcription (IVT)
ampliﬁcation by a 6 cycle PCR. Afterwards antisense RNA (complementary
RNA or cRNA) was synthesized and linearly ampliﬁed by an in vitro
transcription (IVT) of the double-stranded cDNA template. Twenty
micrograms of cRNA was puriﬁed and reverse transcribed into doublestranded (ds) cDNA, whereat unnatural dUTP residues were incorporated at
a ﬁxed ratio relative to dTTP. Puriﬁed ds cDNA was fragmented using a
combination of uracil DNA glycosylase (UDG) and apurinic/apyrimidinic
endonuclease 1 (APE 1) at the dUTP residues followed by a terminal
labeling with biotin. 5.5 µg fragmented and labeled ds cDNA were
hybridized to Affymetrix Clariom S mouse arrays for 16 h at 45 °C in a
GeneChip hybridization oven 640. Hybridized arrays were washed and
stained in an Affymetrix Fluidics Station FS450, and the ﬂuorescent signals
were measured with an Affymetrix GeneChip Scanner 3000 7G. Fluidics and
scan functions were controlled by the Affymetrix GeneChip Command
Console v4.1.3 software.
Sample processing was performed at an Affymetrix Service Provider and Core
Facility, KFB - Center of Excellence for Fluorescent Bioanalytics (Regensburg,
Germany; www.kfb-regensburg.de).
Summarized probe set signals in log2 scale were calculated by using the RMA72
algorithm for Affymetrix Gene Array 2.1 ST or the GCCN-SST-RMA algorithm for
Clariom S array with the Affymetrix GeneChip Expression Console v1.4 Software.
After exporting into Microsoft Excel, average signal values, comparison fold
changes and signiﬁcance p values were calculated. Probe sets with a fold change
above 2.0 fold and a student’s t test p value lower than 0.05 were considered as
signiﬁcantly regulated.
The principal component analysis was performed using the prcomp function in
R (Version 3.2, R Core Team (2016). R: A language and environment for statistical
computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://
www.R-project.org/.) and visualized with the ‘factoextra’ package.
Heatmaps show z-scores, generated with the software GENE-E (https://
software.broadinstitute.org/GENE-E/). Software R i386 3.3.2 was used to create a
volcano plot. The frequency of Gene-Ontology processes and the pathway analysis
(PANTHER pathways) were determined with the Panther Classiﬁcation System73.
Rapamycin and 2-DG assays. Sorted bone marrow progenitors from Cx3cr1gfp/+
mice were cultured as described above. 2-Deoxy-D-glucose (2-DG) (10, 20 or
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30 µmol) or Rapamycin (10 nmol) were added directly after cell sorting for 6 days.
MGC were quantiﬁed based on Hemacolor staining. 2-DG was bought from Sigma
Aldrich and resuspended in Dulbecco´s Phosphate Buffered Saline. Rapamycin was
purchased by Enzo Life Technologies and resuspended in DMSO.
Extracellular ﬂux analysis. A Seahorse XFe96 culture plate (Agilent Technologies)
was coated with 22.4 µg/ml Cell-Tak™ Cell and Tissue Adhesive (Corning®) for one
hour at room temperature after which the Cell-Tak was removed and the wells
were washed once with 200 µl water. The plate was allowed to air dry. (Cell-Tak
was diluted in water, 25 µl of dilution per well, Stock: 1.39 mg/ml). Sorted cMoP
were seeded in duplicate with M-CSF (50 ng/ml) and ﬁxed BCG (106/ml) or with
M-CSF (50 ng/ml) alone as control. After incubation for 6 days, cells were analyzed
by glycolysis stress test on a Seahorse XFe96 Analyzer (Agilent Technologies).
Accordingly, Seahorse base media supplemented with 2 mM L-Glutamine, adjusted
to pH 7.4 was used as assay medium. Injection plates were prepared with 10 mM
Glucose (Port A), 1 µM Oligomycin (Port B) and 50 mM 2-DG (Port C). 2-DG,
L-Glutamine Solution and Oligomycin were purchased from Sigma Aldrich. The
assay protocols were designed using Wave desktop software (Version: 2.4.0.60
Agilent).
FACS analysis of ﬁlipin stained cells. Sorted cMoP and MC from Cx3cr1gfp/+
mice were cultured in 48-well cell bind plates (corning). At day 6 cells were scraped
and washed in FACS buffer (PBS + 1% FBS + 2 mM EDTA). After washing cells
were ﬁxed in 2% PFA and incubated for 20 min at 4 °C. Samples were washed in
HBSS and resuspended in HBSS + Filipin (Filipin III from Streptomyces ﬁlipinensis,
Sigma Aldrich) to a ﬁnal concentration of 50 µg/ml. Samples were incubated for
60 min at RT and directly acquired at a BD LSR Fortessa ﬂow cytometer (Becton
Dickinson).
Confocal microscopy of ﬁlipin stained cells. Giant cell formation was induced in
cMoP as described above using ﬁxed BCG. 6 days after induction, cells were infected
with BCG (MOI 1), stably expressing RFP. After 24 h WGA Alexa Fluor 488
(Thermo Fisher Scientiﬁc) in HBSS was added on live cells for 10 min, then Filipin
staining was performed (abcam cholesterol assay kit) according to manufacturer’s
instructions. Analysis was performed via 740 nm two-photon-microscopy using a
ZEISS LSM 880.
RNA extraction and RT-qPCR. Cells were lyzed in RLT lysis buffer (Qiagen) with
1% β-mercaptoethanol. RNA was extracted with RNeasy MicroKit (Qiagen)
according to the manufacturer’s instructions. RNA was transcribed into cDNA by
iScript™ cDNA Synthesis Kit (Bio-Rad) or by Superscript IV (Invitrogen). RT-qPCR
was performed with absolute qPCR SYBR Green Mix (Thermo Fisher Scientiﬁc) in a
Mastercycler® ep realplex from Eppendorf. mRNA levels were normalized to Gapdh
as housekeeping gene. Primer sequences for Ms4a3 were obtained from Liu et al.13.
Further primer sequences are provided in Supplementary Table 2.
Amplex™ red cholesterol assay Kit. cMoP from Cx3cr1gfp/+ mice were lyzed for
30 min in 0.1% Triton-X after 6 days of culture with respective stimulants.
Amplex™ Red Cholesterol Assay Kit (Thermo Fisher Scientiﬁc) was performed as
recommended by the manufacturer. Cells were counted by ﬂow cytometry with
SPHEROTM AccuCount ﬂuorescent particles (Spherotech) to refer cholesterol
content to the cell number.
Cholesterol oxidase assay. Cholesterol oxidase from Streptomyces (2 mU/ml,
Sigma Aldrich) or PBS (vehicle) was added immediately after cell sorting to cMoP
from Cx3cr1gfp/+ mice. Cells were cultured as described above with appropriate
stimulants. MGC was quantiﬁed by Hemacolor staining. Cell density was evaluated
with SPHEROTM AccuCount ﬂuorescent particles (Spherotech) by ﬂow cytometry.
TNFα production was measured on day 6. Five hours prior to analysis GolgiStopTM
was added together with LPS (100 ng/ml, Invivogen). Staining was performed as
described in the section: TNFα assay. Unstimulated cells served as control.
MBCD assay. Methyl-β-cyclodextrin (MBCD) was purchased from Sigma Aldrich,
dissolved in distilled water and sterile ﬁltered. cMoP from Cx3cr1gfp/+ mice were
cultured after cell sorting with respective stimulants. MBCD (1 mmol) or H2O
(vehicle, equivalent amount for 1 mmol MBCD) were added immediately to the
wells. To reverse the effect of MBCD, MBCD (1 mmol) was added to the wells
together with LDL from human plasma (50 µg/ml, Athens Research and Technology) and PMA (1 µg/ml, Sigma Aldrich). As control, MBCD (1 mmol) with
PMA alone was used. MGC were quantiﬁed after 6 days in culture by Hemacolor
staining. Cell density was evaluated with SPHEROTM AccuCount ﬂuorescent
particles (Spherotech) by ﬂow cytometry. TNFα production was measured as for
cholesterol oxidase assay.
Orlistat assay. cMoP from Cx3cr1gfp/+ mice were cultured under conditions
described above with indicated stimulants. Orlistat (100 µmol, Cayman chemical
group) or an equal amount of ethanol (control) was added directly after isolation
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of cMoP. Cells were cultured for 6 days at 37 °C and MGC were quantiﬁed
by Hemacolor staining or by Hoechst staining. For Hoechst staining cells were
harvested and ﬁxed by Fixation/Permeabilization Solution Kit (BD bioscience)
as indicated by the manufacturer. Samples were stained with 10 µg/ml Hoechst
33342 (Thermo Fisher Scientiﬁc) for 30 min at room temperature. After washing,
samples were analyzed at a BD LSR Fortessa ﬂow cytometer (Becton Dickinson)
and MGC were quantiﬁed as polyploid cells (N > 4) from histogram peaks. Cell
density was evaluated with SPHEROTM AccuCount ﬂuorescent particles
(Spherotech) by ﬂow cytometry. TNFα production was measured as for cholesterol
oxidase assay.
Lipid extraction and analyses using liquid chromatography mass spectrometry. cMoP and MC from Cx3cr1gfp/+ mice were isolated and cultured under
conditions described above with indicated stimulants. On day 6 cells were washed
in cold washing buffer (PBS + 1% lipid-free BSA), scraped and cell number was
measured with a TC20 automated cell counter (Bio-Rad). Samples were centrifuged
and washing buffer was discarded. Cell pellets were shock frozen in liquid nitrogen
and kept at −80 °C until further processing. Samples were resuspended in 100 µl of
PBS and lipids were extracted using a modiﬁed Bligh and Dyer’s method74. Brieﬂy,
chloroform:methanol (1:2, v/v) was added and the mixture was vortexed. The
samples were placed on a thermomixer and shaken at 1000 rpm for 2 h at 4 oC.
Phase separation was introduced by adding chloroform and water, followed by
centrifugation. Lipids in the lower organic phase were collected. The aqueous phase
was re-extracted and the two organic extracts were pooled and concentrated by
drying under vacuum using a Centrivap (Labconco Corporation). The dried lipid
ﬁlm was resuspended in 100 µl of chloroform-methanol (1:1, v/v) and spiked with
internal standards (d7-cholesterol (Avanti Lipidy)) prior to LC-MS/MS analyses.
Sterols were analyzed using atmospheric pressure chemical ionisation (APCI) triple
quadrupole mass spectrometer (SCIEX Qtrap 6500+) with upfront liquid chromatography (Agilent Technologies). Separation of sterols was achieved using a
Poroshell 120 SB-C18 column (3.0 × 50 mm, 2.7 µM, Agilent Technologies), which
is a modiﬁcation of the method developed by McDonald et al.75. For mass spectrometry analyses, the instrument was operated in the multiple reaction mode
(MRM). For quantitation, area under the curve was obtained for each sterols
measured and normalized to the internal standard and cell number. External
calibration was made for each sterol to adjust the response factor for each lipid
relative to cholesterol.
MethoCultTM assay. cMoP and iMoP from Cx3cr1gfp/+ mice were isolated and
resuspended in IMDM + 2% FBS to a cell density of 105/ml. The cell suspension
was mixed with MethoCultTM Medium M3434 (Stem Cell Technologies) to a cell
density of 104/ml. 1.1 ml of the cell suspension was distributed per culture plate.
The analysis was performed in duplicates. At day 10 after culture colony formation
was counted. A colony was deﬁned as a cell formation of at least 10 cells.
Statistics and reproducibility. For Statistical analysis, Prism 8.0 (GraphPad software) was used. Results were considered statistically signiﬁcant if p values were
≤0.05. (ns, not signiﬁcant; *p < 0.05; **p < 0.01; ***p < 0.001, ****p < 0.0001).
Individual statistical tests and the number of biologically independent samples are
described in detail in the ﬁgure legends. In short, two-tailed unpaired student’s t-test
was used to compare the mean of the two groups. One- or two-way ANOVA was
applied for multiple comparisons, followed by a multiple comparison analysis. The
statistical analysis was based on n, indicating the number of independent biological
samples or mice as described in detail in the respective ﬁgure legends. Experimental
repetitions in the case of representative data were performed as follows. Phalloidin
and Hoechst stainings of cMoP were performed in at least three independent
experiments (Fig. 1a). Hemacolor stainings, as presented in Fig. 1d, were conducted
in four independent experiments. The ﬁlipin staining in Fig. 4a depicts one
representative out of three independent experiments. Hemacolor stainings in Supplementary Fig. 3b were performed of n = 15 and in Supplementary Fig. 3c of n = 6
biologically independent samples. Cytospins of bone marrow precursors were
performed in three independent experiments (Fig. 6d). Granuloma stainings shown
in Fig. 8c were conducted with at least n = 5 mice. Immunoﬂuorescence stainings of
livers after cell transfer were performed for n = 5 mice (Fig. 9a and Supplementary
Fig. 6d). Individual 3D reconstructions of GFP+ transferred cells were performed
for ﬁve images (Fig. 9c).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
All microarray data are deposited at the National Center for Biotechnology Information
Gene Expression Omnibus public data base. The accession numbers for the ‘Genom-wide
expression study of cMoP and monocytes from murine bone marrow compared to their
differentiated descendants’ (Fig. 3 and Supplementary Fig. 2) is GSE117456 and for the
‘Genom-wide expression study of cMoP and iMoP from murine bone marrow’ (Fig. 7) is
GSE117460. Other data supporting the results can be provided by the authors upon
reasonable request.
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